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Abstract 
The NG2 proteoglycan is a molecular marker of oligodendrocyte precursor cells (OPCs) and is 
abundantly expressed by a variety of tumours. Published results show that NG2 influences 
proliferation, migration, and has neuromodulatory effects. Like other type-1 transmembrane 
proteins, NG2 is subjected to regulated intramembrane proteolysis (RIP), generating a large 
ectodomain, a C-terminal fragment (CTF) and an intracellular domain (ICD) by the sequential 
action of α- and γ-secretases. The cleavage of NG2 is constitutive and enhanced by neuronal 
activity. Functional roles of the NG2 protein domains have so far been shown for the full-length 
protein, the released ectodomain and CTF, but not for the ICD.  
This study characterized the role of the NG2 ICD in a murine OPC cell line (Oli-neu), primary 
OPCs and human embryonic kidney (HEK) cells. It was found that the cleaved NG2 ICD has a 
predominantly cytosolic expression including the distal processes of OPCs. A small fraction of 
the protein exhibits a nuclear localization. Immunoprecipitation coupled with Mass Spectrometric 
analysis indicated that the NG2 ICD modulates mRNA translation and cell-cycle kinetics. 
Functional studies showed that ICD overexpression results in an upregulated translation of 
mRNAs as well as a shift of the cell population towards S-phase. NG2 ICD increases levels of 
the active (phosphorylated) form of mTOR and modulates downstream signaling cascades. 
These include increased phosphorylation of p70S6K1 and increased expression of eEF2. 
Strikingly, levels of FMRP, a translation repressor and RNA-binding protein that is regulated by 
mTOR/S6K1/eEF2 were decreased upon ICD overexpression. De novo proteomic profiling by 
pulsed-SILAC method after NG2 ICD overexpression revealed that proteins regulating DNA 
replication, cell differentiation and apoptosis were highly enriched in the NG2 ICD-
overexpressing population.  
This study establishes that the NG2 ICD, after release by cleavage, acts as a regulator of 
translation and cell cycle progression in OPCs by modulating the mTOR pathway, a known 
global translational regulator. It also influences levels of FMRP, a protein responding to network 
activity and a well-characterized repressor of translation.  Findings from this study additionally 
help to explain why tumours exhibiting enhanced rates of translation and rapid cell cycle kinetics 
express high levels of NG2. 
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1. Introduction 
1.1 Cell types in CNS 
The central nervous system (CNS) is composed of neurons and glia cells that work 
together in a highly coordinated fashion to elicit a various neural response. Neurons are 
responsible for receiving, processing, integration and propagation of information via 
synapses. While neurons play the pivotal role as an information processor, glial cells 
have long been known for their role as a supporting system for neurons in the CNS. 
Their major functions discussed for quite a time involves providing protection, nutritional 
support, anchoring and facilitate neuronal conduction. However, detailed research on 
glial cells, especially in the last 20 years shed light on glial functions extending beyond a 
mere support system in CNS. These findings revealed that glial cells are essential for 
neuronal development, axon guidance, synaptic transmission, and neurotransmitter 
release. These cells are an essential part of the neuronal network and intriguing topic of 
neuro-research.  
1.2. History of glia cells  
The history of glia cells goes back to the mid-1800’s where a pathologist, Rudolf 
Virchow, coined the term ‘neuro-glia’ in his book published in 1856 and the same year 
another eminent scientist, Henrich Müller, made the first drawings and description of 
glial cells (today known as Müller glia cells in the retina). In 1871, Camileo Golgi 
described oligodendrocytes and astrocytes in his book and in 1893, Michael Von 
Lenhossek coined the term for ‘astrocytes’ describing it as a star-shaped cell. Robert 
Remak first observed and described the ‘medullated fibers’ in PNS which were later 
termed as ‘myelin’ by Rudolf Virchow in 1854. Pio del Rio-Hortega, in 1919, separated 
two other cell types and named one as oligodendroglia (first described by Robertson, 
1899) in 1921 and he also proposed that oligodendrocytes produce myelin, but this 
theory took a long time to be established and was fully accepted in 1962 after the 
published work of Richard Bunge where he showed by electron microscope pictures 
that oligodendrocytes produce myelin sheath and wrap axons. 
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Fig.1.1.  Pictorial representation of different glia types in the nervous system (Source: Google 
images). 
 
1.3. Development of glia cells 
Owing to their ‘stem-cell-like’ property, the development of glial cells itself is a 
fascinating topic. By using different models and in vitro systems, the origin of 
oligodendrocytes and Schwann cells can be traced, and other cell types also can be 
distinguished based on their molecular markers. Neuronal and glial cell types of the 
mature CNS originate initially from neural precursors (NPCs) in the embryonic neural 
tube. The differentiation of NPCs into neurons and glial cells is highly controlled in a 
spatiotemporal manner in response to surrounding signaling cues which includes 
soluble morphogens like Sonic hedgehog (Shh) and bone morphogenetic protein 
(BMP). After fate switching from NPCs to glia, different kinds of glial cells can be 
distinguished by their morphology and expression of molecular markers. The table 
below represents a summary of the origin, molecular marker and main functions of main 
glia types.  
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Table 1. Glia cells at a glance 
Cell type Developmental area and time 
point 
Identifying markers Main functions 
Astrocytes Neural Stem cells (NSCs) 
transitions from neurogenesis to 
gliogenesis in the Ventricular 
Zone (VZ), in the spinal cord,  
this switching happens at E12.5 
and in the cortex at E16-18 in 
rodents. 
 
Astrocyte Precursor 
Marker: Glast, 
FABP7, FGFR 
 
Mature Astrocyte 
Markers: GFAP, 
S100B, AldoC, Glt1 
1. Neurotransmitter release 
and clearance. 
2. Shaping extracellular space 
surrounding neurons.  
3. Pre and post-synaptic 
assembly of excitatory 
synapses during early 
postnatal development.  
Oligodendrocytes Detected in Sub-ventricular zone 
(SVZ) of the brain and spinal cord 
during mid-gestation in rodents.  
OPC stage: NG2, 
PDGFR 
Mature OL: MBP, 
PLP, MAG.  
1.  Myelination.  
2. Neuronal protection.  
3. Metabolic support to 
neurons 
Microglia Microglia, unlike other glia cells, 
are of myeloid origin, and they 
developed from yolk sac (YS) 
primitive macrophages during E7-
E10. 
TMEM119, Iba1 1. Neuronal survival and 
death 
2. Synaptogenesis and 
synapse pruning.  
3. Cross-talk with the 
periphery.  
Schwann Cells Schwann cell precursors originate 
from neural crest at around E12-
13 and subsequently produce 
immature Schwann cells at E16-
18 in rodents.  
Precursor stage: 
BFABP, Connexin 29, 
PMP22 
 
Myelinating Schwann 
cells:  S100, Sox 10, 
EGR2 
1. Myelination in PNS.  
2. Response to nerve injury 
and maintenance.  
3. Nerve fasciculation. 
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1.4. Lineage plasticity of NG2-glia cells  
Nerve/Glial antigen 2 (NG2) is a member of the chondroitin sulfate proteoglycan family, 
and NG2+ glial cells are found in high abundance in both grey and white matter, 
comprising around 5-8% of the total population in CNS. (Pringle et al., 1992, Dawson, 
2003).  The history of NG2-Glia started nearly thirty years ago, when a group of neural 
progenitors cells, called O-2A progenitors, found to express prominent molecular 
markers, NG2 and PDGFRα. Developmentally, O-2A cells originate from the germinal 
ventricular zone of embryonic brain and spinal cord and later proliferate and migrate 
through developing CNS forming an even distribution throughout gray and white matter 
(Richardson et al., 2006, Miller, 1996). The progeny type of O-2A cells remained 
debatable for a decade where some research data revealed that besides producing a 
large pool of myelinating oligodendrocytes, they could also give rise to so-called type-2 
astrocyte cells in vitro (Raff et al., 1983). Matthias et al., in 2003, by using a transgenic 
mouse model also showed the presence of two distinct cell populations where one was 
positive for both NG2 and S100β (astrocytic marker) and the other was only positive for 
NG2 but not for S100β, suggesting the existence of shared Oligodendrocyte/astrocyte 
lineage. It has been proposed and shown that during development the fate of NG2+ 
cells are not restricted to oligodendrocyte (OL) lineage, rather they contribute to 40% of 
protoplasmic astrocytes in the grey matter of the ventral forebrain (Zhu et al., 2008, 
2011, Huang et al., 2014, Nishiyama et al., 2014), although this astrogliogenic property 
of NG2+ cells is lost shortly after birth.  
There are also evidences that reactive astrocytes at sites of CNS injury are generated 
by the NG2+ cells (Leoni et al., 2009, Alonso et al., 2005), although Tripathi et al., in 
2010, in their EAE model of demyelinating disease, showed that in adult mouse spinal 
cord, NG2+ cells generate a major population of oligodendrocyte (OL) lineage cells, 
including mature and differentiated OLs, with a very few astrocytes or neurons. There 
are also some publications reporting that NG2+ cells can generate a fewer numbers of 
neurons during adulthood (Rivers et al., 2008, Guo et al., 2010, Robins et al., 2013), 
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although this topic remains highly controversial as other reports provide no evidence for 
neurogenesis from NG2+ glia cells (Dimou et al., 2008, Zhu et al., 2011).  
The ambiguous nature of the experimental data to prove that NG2+ glia can give rise to 
both oligodendrocytes and astrocytes, put a question on the terminology of ‘O-2A’ cells 
which gradually replaced by the name of Oligodendrocyte Precursor cells or OPCs as 
these cells are, so far, the exclusive and well-established source of mature OLs 
generation. OPCs can be distinguished from the other glial cell types by the expression 
of molecular markers PDGFR-alpha and NG2.  
The major distinguishable features of NG2+ OPCs lie in their ability to maintain a 
resident population of undifferentiated cells by self-renewal while continuously 
producing mature oligodendrocytes throughout adulthood. However, OPC proliferation 
and differentiation are different in the grey and white matter, where white matter NG2+ 
OPCs show a stronger proliferative response to PDGF-AA than those in grey matter 
(Hill et al., 2013). Another intriguing characteristic of OPCs which separates them from 
astrocytes is their robust migratory nature which involves both radial and tangential 
migration (Tsai et al., 2012, Bayraktar et al., 2015). Moreover, NG2+ OPCs have been 
shown to form a synapse with neurons and serve as a post-synaptic compartment 
which makes them exclusive in this context (Bergles et al., 2010, Sakry et al., 2014, 
reviewed in Steinhaüser and Dietrich, 2015). As NG2+ OPCs are endowed with a 
distinct molecular pattern and functional properties, they are postulated as the fourth 
glia cell type in the CNS.  
 1.4.1 Development of NG2+ OPC 
Oligodendrocytes (OL), the myelin-producing cells of the Central Nervous System 
(CNS), develop from Oligodendrocyte precursor cells (OPCs). NG2+ OPCs are also 
known as polydendrocytes because of their branched morphology. The intriguing 
features of OPCs are that they retain self-renewing capability and can differentiate into 
OLs in the adult CNS. These features allow them to regenerate myelin by producing 
myelin-forming mature OLs in the case of age-dependent and injury-related myelin loss.  
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OPCs are identifiable in CNS by the markers NG2 and PDGFR-alpha. Neural 
precursors that produce oligodendrocyte lineage cells are first detected by E12-14 in 
rodents by the expression of PDGFR mRNA (Pringles et al., 1992, Pringles and 
Richardson, 1993) in ventricular germinal zones (VZ) in the brain and spinal cord.  The 
position of OPCs corresponds to motor neurons progenitor(pMN) domain, which just 
before OPC production, give rise to motor neurons (Rivers et al., 2008, Richardson et 
al., 1997). After their appearance, the ventrally derived OPCs proliferate and migrate to 
populate other CNS regions so that by E17, there is even distribution of NG2+ PDGFR+ 
cells throughout spinal cord, hindbrain and basal forebrain (Nishiyama et al, 1996).  
After the first wave of OPC production from the pMN domain in VZ, a second wave 
produce more OPCs in the dorsal cord at around E15.5 in mice. Dorsally derived OPCs 
do not migrate as much as ventrally derived ones and they comprise approximately 
20% of total OPC population.  
At around E18.5 in mice, some OPCs in the spinal cord start differentiating into mature 
OLs with an expression of Myelin Basic Protein (MBP) and Proteolipid Protein (PLP). 
They first appear in developing white matter where they start myelinating surrounding 
axons and OL production reaches its peak ~2-4 week postnatal in mice throughout the 
white and grey matter.  
1.4.2 Specification of OPC into matured OLs 
Differentiation of OPCs into matured OLs is tightly controlled by a milieu of transcription 
factors and diffusible morphogens. In the precursor of Motor Neurons (pMN) domain, 
the specification of OPCs is triggered by Sonic Hedgehog (Shh) signal which acts via 
the downstream mediator Gli proteins, which in turn, activate lineage-determining 
genes.  Shh also collaborates with Notch pathway which plays a key role in neuron-glia 
fate switching; activated notch promotes neurogenesis over gliogenesis during the first 
wave of OPC production in pMN domain.  
Development of the OLs also depends on Sox transcription factors. While Sox9 
promotes oligodendrocyte specification, Sox10 regulates terminal differentiation of OLs. 
Sox10-deficient neural stem cells cannot produce myelin when transplanted into a wild-
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type host establishing a direct cell-autonomous role of Sox10 for myelin production 
(Stolt et al., 2004, Woodruff et al., 2001).  
The most important and well-studied transcription factors for OPC differentiation are the 
Olig genes. Shh activates the transcription factor, Olig2, which is an absolute 
requirement for the sequential production of motor neurons and OPCs from the pMN 
domain (Lu et al., 2002, Zhou and Anderson, 2002). Olig1 is structurally very similar to 
Olig2 and expressed coordinately, but studies found that it is not required for OPC 
specification in the spinal cord and is not expressed until ~E18.5 in mice (Fu et al., 
2009).  
Olig2 and Sox10 share a common target to drive the expression of another transcription 
factor called myelin regulatory factor (Myrf), which is strongly induced during the early 
onset of OL differentiation (Hornig et al., 2013) and promotes OL maturation and 
myelination (Review by Ben Emery and Q. Richard Lu., 2015, Emery et al., 2009, 
Bujalka et al., 2013). Recently, another less well-known transcription factor YY1 came 
out to be one of the regulators of OPC specification. Reduced YY1 causes arrested 
OPC specification and halted maturation. (He et al., 2007).  
 
 
 
 
 
 
 
 
Fig 1.2. The lineage of NG2+ OPCs (Taken from Girolamo et al., 2011) 
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As OPCs start to differentiate into matured OLs, they gradually lose the expression of 
NG2+ PDGFR+ antigenic profile and enter an intermediate pro-oligodendrocyte stage 
which is recognized by O4-immunoreactivity (Sommer and Schachner, 1981, Bansal 
and Pfeiffer, 1989). The gradual progression of NG2+ PDGFR+ to NG2+O4+ and finally 
to O4+MBP+ stage takes around P9-P20 in mice (Polito A and Reynolds R, 2005). 
Mallon et al. (2002) using a transgenic mouse model where the EGFP protein was 
expressed under the PLP promoter, proposed that there is two distinct types of NG2+ 
cells during the development of the neocortex where one population was NG2+/EGFP+, 
and another one was NG2+/EGFP-. The advent of single-cell RNA sequencing (scRNA-
Seq) now present a solid platform to trace OL-lineage cells and subtypes in an 
extensive manner and already provides information on the heterogeneity of OL cells in a 
spatiotemporal manner (Bruggen et al., 2017, Marques et al., 2017).  
1.4.3 Expression of NG2 outside CNS 
Although NG2 was originally described and most-discussed in the context of CNS, the 
protein is also expressed by other various cell-types, mostly those in a precursor state. 
In the developing rodent limb, NG2 is expressed by immature chondroblasts (Nishiyama 
et al., 1991, Fukushi et al., 2003) and a similar pattern of NG2 appearance and 
disappearance was detected in osteoblast to osteocyte transition in maturing bone 
(Fukushi et al., 2003).  
Keratinocyte stem cells produce keratinocyte precursor cells which also express NG2+, 
and they have a range of progenies (Legg et al., 2003, Ghali et al., 2004, Kadoya et al., 
2008). NG2 expression is also prominent and well-established in the developing 
vascular system. Beside cardiomyocytes expressing NG2, smooth muscle cells in the 
macrovasculature and pericytes in the microvasculature express NG2 (Grako et al., 
1995, Schlingemann et al., 1991, Ozerdem et al., 2002).  
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1.5. Role of glia cells in neuronal synapses 
The primary place of intercellular information flow in the nervous system occurs at the 
junctions between neurons, known as synapses. Till the end of the 1990s, synapses 
were envisioned as a two-compartment system (classical bi-partite synapse), composed 
of one pre-synaptic element releasing neurotransmitters in the synaptic cleft and one 
post-synaptic element receiving the information through activation of invariant number 
and type of receptors. (Choquet et al., 2013). However, last 20 years of research tells 
Fig.1.3. Summary of NG2 expression (Credit: Human Protein Atlas) 
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us a different story with the concept of emerging and well-established participation of 
glia cells in synaptic functions.  
1.5.1. Role of glia in synaptic functions 
Extensive recent studies on the role of glia cells in synaptic biology revealed that glia 
could modulate neuronal synapse formation, synaptic strength and the removal of 
synapses (e.g., by synaptic pruning), challenging the common notion that synapses are 
solely modulated by neurons and the neuronal network. ((Ullian et al., 2001, Bergles et 
al., 2010, Wu et al., 2007, Garrett et al., 2009).  
1.5.2. Role of Neuron-OPC synapse 
Interestingly, recent discoveries revealed an intriguing relationship between the 
progenitor cells of OLs (Known as Oligodendrocyte Precursor Cells or OPCs) and 
neurons. It has been found that these cells form their own glutamatergic synapses with 
axons (Bergles et al., 2000, Lin et al., 2005), serving as a post-synaptic compartment, 
and harbors a wide array of GABA and glutamate receptors (Maldonado et al., 2011). 
To date, OPC are the only glial cell population that are known to form chemical synapse 
with neurons directly. It has also been shown that activity influence OPC proliferation 
(Mangin et al., 2012) and OPC can cross-talk with the neuronal network as well (Sakry 
et al., 2014, Sakry, et al., 2015) making these cells extremely interesting to study 
further.  
1.5.3. Role of Astrocytes in synapse 
Astrocytes are the most numerous constituents of the CNS and play a critical role in 
brain functions. Due to their proximity to neurons, astrocytes sense synaptic modulation 
efficiently and can control synaptic behavior. Astrocytes harbor many neurotransmitter 
receptors and thus respond to synaptic information produced by the neuronal activity. 
Studies have found that addition of astrocytes or astrocyte-derived medium in RGC 
neurons promote formation of excitatory synapses (Ullian et al., 2001) and research on 
the underlying molecular mechanism behind this phenomenon revealed that astrocytic 
release of apolipoprotein A bound to cholesterol (Goritz et al, 2005), TSP-1 and 2 
(Christopherson et al., 2005), glycoprotein hevin  and SPARC (Kucukdereli et al, 2011) 
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facilitates synapse formation and pre-synaptic release. Hevin and SPARC are also 
reported to induce post-synaptic membrane insertion of Glu1-A containing AMPAR (α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (Allen et al, 2012).  
During development, it is essential to fine-tune synapse formation and elimination for a 
mature brain-circuit and astrocytes play a key role in synapse loss too. It has been 
found that astrocytes express phagocytic genes and engulf synapses throughout 
adulthood via MEGF10 and MERTK pathways (Chung et al., 2013).  
Astrocytes are also involved in regulating neuronal-activity by potassium and calcium 
buffering and uptake of neurotransmitters, Glutamate (by GLT-1, GLAST) and GABA 
(by GAT-1) and thus they are necessary for synaptic plasticity and maintenance (Zhang 
et al., 2017, Poskanzer et al., 2016, Thrane et al, 2013, Tanaka et al., 1997). 
1.5.4. Role of Microglia in synapse 
Microglia are the resident macrophages and phagocytes in the CNS, comprising 10% of 
the total glia population in human and around 20% in the rodent brain (Kettenmann et 
al., 2011). Microglia is largely known for regulating neuroinflammatory procedure, but 
they also play a key role in maintaining synapse architecture using their motile 
processes interacting with boutons and spines. Direct interaction between microglia and 
synaptic elements is already established by EM pictures (Tremblay et al., 2010).  
Phagocytic microglia engulf pre and post-synaptic elements in the hippocampus and 
retinogeniculate system (RGS) during the first weeks after birth (Paolicelli et al., 2011, 
Schafer et al., 2012). This procedure is largely controlled by the CX3CR1 receptors in 
hippocampus and CR3 in the thalamus, expressed by microglia. CX3CR1-knockout 
mice show impaired social behavior, presumably caused by delayed 
electrophysiological properties of synapses during development (Paolicelli et al., 2011). 
There is also reference that microglia modulate synaptic plasticity by TNF-alpha 
mediated LTP and LTD induction in developing CNS (Wang et al., 2004, Stellwagen et 
al., 2006).  
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1.5.5.  Role of Oligodendroglia and Schwann cells in synapse  
The well-established role of myelin-producing oligodendrocytes and schwann cells is to 
ensheath axons to enable saltatory neuronal conduction in the CNS and PNS 
respectively. But more recent studies on myelin biology demonstrate another crucial 
role of myelin in CNS: it contributes to cognition and learning by modulating synaptic 
plasticity (Hoz et al., 2014, Scholz et al., 2009). The underlying molecular mechanism 
involves myelin protein and their ability to suppress axon sprouting and synaptogenesis 
(Schlegel et al., 2012). Early studies showed that transection of the developing optic 
nerves of the developing mice significantly reduced OPC proliferation rate (Barres and 
Raff, 1993) and produced thinner myelin sheath (Demerens et al., 1996). Neural 
impulse activity has been shown to inhibit PNS myelination via changing membrane 
properties of axons and releasing signaling molecules (Stevens et al., 1998) and on the 
other hand myelin sheath formation by individual OLs was increased by neuronal 
stimulation of synaptic vesicles (Reviewed in Forbes and Gallo, 2017, Mensch et al., 
2015). Activity-dependent release of Adenosine appears to play a dual role in 
myelination, as in CNS, Adenosine is an active axon-glia transmitter promoting 
myelination and in PNS, it has been shown to inhibit myelination (Stevens and Fields, 
2000, Stevens et al., 2007). Cellular studies on myelination have found that this process 
can be influenced by action potential firing in axons (Shrager et al., 1995, Stevens et al., 
1998, Wake et al., 2011). Elevated neuronal activity in premotor areas has been shown 
to influence myelin patterning in callosal projections (Gibson et al., 2014) and recently, 
Etxeberria et al., in 2016, showed in their study that experience-dependent activity can 
change the length of myelin internodes and thus results in altered action potential 
conduction velocity.  
Recent discoveries suggest that oligodendrocytes and axons are metabolically coupled 
as glycolytic oligodendrocytes provide lactate to neurons for aerobic ATP generation 
(Fünfschilling et al., 2012, Lee et al., 2012) and ensheathing glia provide trophic support 
to metabolically isolated neurons (Nave, 2010). Oligodendroglia are also reported to 
provide supportive biomolecules to neurons via exosome upon receiving neuronal 
signals. (Frühbeis et al., 2013). Micu et al., in 2016, showed that axonal activity triggers 
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NMDA receptor (N-methyl-D-aspartate)-mediated calcium response in myelin-producing 
oligodendrocytes (Micu et al., 2016).  
1.5.6. Activity-dependent local translation and myelination 
Neuronal activity induces a plethora of structural and functional changes in the post-
synaptic compartment of a given synapse. The activity-driven alterations include rapid 
local translation, trafficking to and from the postsynaptic membrane, receptor 
expression, and internalization and altered intracellular signaling pathways. Most of 
these influenced synaptic events finally control synaptic strength, dendritic spine 
outgrowth and potentially mediate retrograde signaling (Kopec et al., 2007, Tanaka et 
al., 2008, Yang et al., 2008). The molecular events occurring during synaptic 
transmission are rapid and well-coordinated, and growing evidence suggests that 
stimuli-induced local translation lay the foundation of synaptic plasticity. Synaptic 
modulation within the neuronal network provides a mechanism for learning and 
memory, proper cognitive functions and stabilization of the neuronal network itself 
(Trinidad et al., 2013). Many of the neuronal mRNAs are actively transported via motor 
proteins in a form of mRNP (messenger ribonucleoprotein) granule to localize in 
dendrites or distal processes where they generally remained in a translationally 
repressed stage and later translated upon receiving external stimuli (Martin et al., 2009, 
reviewed in Sutton and Schuman, 2006, Wang et al., 2010), for example, In OLs, MBP 
mRNA has been shown to be transported into the distal processes where myelination 
takes place (Ainger et al., 1997, Smith et al., 2004).  One of the most well-studied and 
emerging case in this context is Fragile-X syndrome (FXS), an intellectual disorder 
caused by mutation of an activity-dependent neuronal protein, FMRP, mutation of which 
leads to exaggerated translation and impaired synapses. Strikingly, FMRP has been 
reported to translationally repress MBP mRNA (Darnell et al., 2011, Li et al., 2001) and 
FXS patients often display myelin abnormalities (Hass et al., 2009, Hoeft et al., 2010).  
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1.6. Cellular functions of NG2 protein 
1.6.1. Role of NG2 in modulating neuronal network 
NG2 has long been considered mainly as a cell surface anchor or adhesion molecule 
due to the well-established interaction with Collagen V and VI and integrin complex 
(Burg et al., 1996, Tillet et al., 2002). Although, ECM remodeling is an important event 
in synapse formation, supporting data for the role of NG2 in the neuronal network was 
limited until the 2000’s. Bergles et al., in their work in 2000, demonstrated that NG2+ 
OPCs could receive synaptic input from neurons and focus on NG2’s role in this context 
has gained massive attention since then. Sakry et al., in 2014, revealed that the two 
LNS domains in the cleaved NG2 extracellular domain modulated neuronal synaptic 
AMPAR currents and kinetics of pyramidal neurons in somatosensory cortex in rodents 
most likely by influencing the AMPAR subunit composition. Moreover, NG2-Knockout 
mice (NG2-KO) displayed reduced NMDAR-induced LTP and impaired sensory input-
related behavioral differences compared to wildtype (Sakry et al., 2014).  NG2+ OPCs 
serve as a post-synaptic compartment as NG2-KO mice show post-synaptic phenotype 
changes by LNS domain while pre-synaptic changes remain unaltered. NG2 cleavage is 
also increased by neuronal activity and the cleaved product has been shown to exert 
neuromodulator effects by regulating the expression level of PTGDS, a known 
neuromodulator (Sakry et al., 2015) (Fig 1.4).  
Introduction      
 
21 | P a g e  
 
 
Fig 1.4. Diagrammatic representation of an NG2+ OPC-Neuron synapse (Taken from Sakry et al., 
2014) 
 
1.6.2. Cell motility 
OPCs are highly motile as they migrate through the developing CNS and NG2 plays a 
crucial role in the regulation of adhesion and migration. NG2 facilitates cell motility by 
binding collagen VI through the extracellular central D2 domain (Burg et al., 1996). 
Moreover, NG2 has been shown to increase motility in vascular endothelial cells by 
interacting with galectin3/α3β1 integrin complex in trans on the endothelial cell surface 
(Fukushi, 2004).  Investigation of the underlying molecular mechanism behind this event 
revealed that PKCα-dependent phosphorylation at the Thr2256 residue of the 
intracellular part of NG2 was required for the increased cell motility (Mackagiansar et 
al., 2004, 2007) and this phosphorylated epitope colocalized with integrin at the broad 
lamellipodia at the leading edges of motile cells (Stallcup et al., 2008). A study by 
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Biname et al. has reported that NG2 tightly controls directional OPC migration and cell 
polarity (Biname et al., 2013) by stimulating RhoA activity at the cell periphery via 
interaction with Syx1/Mupp1 signaling. It is also reported that NG2+ glia responds to 
soluble chemotactic factors like Netrin 1 and class 3 semaphorins (Spasskey et al., 
2002). PSA-NCAM and N-cadherin also regulate NG2-mediated cell motility effect in 
vitro (Zhang et al., 2004, Schnadelbach et al., 2000).  
1.6.3. Cell proliferation and survival 
To obtain even distribution throughout the major areas of the CNS, OPCs rely on their 
proliferative ability as well as migration and PDGF-AA and FGF are essential for OPC 
proliferation (Goretzki et al., 1999). The core protein of NG2 contains binding sites for 
these receptors scattered through D2 and D3 domain of extracellular region. It has also 
been shown that treatment with NG2 antibody reduces OPC proliferation in response to 
PDGF (Nishiyama et al., 1996).  Phosphorylation by ERK at the Thr-2314 residue in the 
intracellular domain of NG2 also plays a role in proliferation (Makagiansar et al., 2007).  
Interestingly, the NG2-dependent effect on the α3β1 integrin signaling cascade 
activates PI3K/Akt signaling which plays an important role in cell survival (Downward et 
al., 2003, Joy et al., 2003). The NG2-transfected U251 glioma cell line was reported to 
be more resistant to treatment with TNF- α and other chemotherapeutic drugs than the 
parental ones (Chekenya et al., 2008) and NG2-knockdown is also effective in triggering 
apoptosis in gliomas endogenously expressing NG2. Recent findings by Maus et al., in 
2015, revealed that NG2 also binds a protease, OMI/Htra2 via the intracellular PDZ-
binding domain, and by sequestering this protein, it exerts a protective role in OPCs.  
1.6.4. Cytoskeleton reorganization  
Since the contribution of NG2 in cell migration and polarity formation is already well-
established by separate groups, it was anticipated that NG2 elicits these changes by 
modulating the composition of underlying cytoskeleton framework. The intracellular part 
of NG2 is particularly important in this context as it interacts with several scaffolding 
proteins like MUPP1 (Stegmuller et al., 2003) and GRIP (Barritt et al., 2000) via its PDZ 
domain. It has also been reported that NG2 intracellular region interacts with Syntenin-1 
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which mediates cytoskeletal rearrangements at the plasma membrane (Chatterjee et 
al., 2008).  There is also evidence of stimuli-dependent NG2 interaction with two distinct 
subdomains of the actin cytoskeleton (Lin et al., 1996).  
1.6.5 Role of NG2 in Glioma 
Glioblastoma Multiforme (GBM) is the most prominent and aggressive type of brain 
tumours with patients having a median life expectancy of only 14 months and less than 
25% of patients surviving 24 months (Stupp et al., 2005). The source of glioma, being 
heterogeneous, includes neural stem cells, astrocytes, and glial progenitor cells. The 
involvement of glial progenitors, in this context, inevitably comes with their molecular 
signatures like NG2, PDGFR and Olig2 as these are highly abundant in tumour cells 
(Chekenya et al., 2002, Bouvier et al., 2003, Shoshan et al., 1999).  
Several studies on the role of the NG2 proteoglycan in tumours suggest that the 
expression of NG2 can be correlated with the degree of malignancy (Chekenya et al., 
2002, Schrappe et al., 1991). Owing to the fact that NG2+OPCs are surprisingly 
abundant in the CNS (more than 70% of the cycling progenitors) (Goldman et al., 2005, 
Dawson et al., 2003), they are likely to constitute a major cell population in which 
accumulating mutations can lead to tumourigenesis. 
The main functions of NG2 include rapid cell proliferation, increased cell survival, and 
migration which are also highly beneficial for tumour survival and progression. This may 
explain high expression of NG2 in glioma and other type of tumours. NG2 knock-down 
has been reported to slow down tumour progression (Chekenya et al., 2008) and 
overexpression of it in melanoma has been demonstrated to increase tumour growth 
(Burg et al., 1998).  
Due to the high expression level of NG2 by tumours, it has been chosen as a cancer 
therapeutic target and treatment with monoclonal antibody, siRNA or shRNA-mediated 
knockdown has been shown to reduce tumour proliferation and increased tumour 
necrosis in murine models of melanoma (Wang et al., 2011, Wang et al., 2010).  
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1.7. Regulated intramembrane proteolysis (RIP) 
1.7.1 Mechanism of regulated intramembrane proteolysis (RIP) 
Regulated Intramembrane Proteolysis (RIP) is a cellular process that links external cues 
with intracellular events. RIP is a highly regulated proteolytic event where a 
transmembrane protein (type 1 or type 2) is cleaved by a group of proteases (iCLiPs, 
Intramembrane Cleaving Proteases), either constitutively or in response to ligand 
binding, yielding a soluble intracellular fragment called intracellular domain (ICD).  
iCLiPs are multi-span, integral membrane proteins, the active sites of which are 
exposed to the hydrophobic environment, typically embedded in the predicted 
transmembrane domain (TMD) region. For the most studied cases, optimal action of 
iCLiPs requires substrate priming where members of disintegrins and metalloproteinase 
(ADAM family), matrix metalloproteases or BACE family (BACE1 and BACE 2) 
proteases cleave off the extracellular domain at the transmembrane domain (TMD), an 
event known as ‘Shedding’. The released ectodomain is released either in the vesicular 
lumen or the extracellular matrix and often exhibits unique biological properties. The 
shedding results in generation of a membrane-bound stub (also known as C-terminal 
fragment or CTF) which is then subjected to a second cleavage event within its 
transmembrane domain releasing a shorter peptide secreted in the extracellular milieu 
and an intracellular domain which is released into the cytosol. The intracellular domains 
sometimes act as signaling molecules and often have a defined biological role. (Lal et 
al., 2010., Lichtenthaler et al., 2011) (Fig 1.5). 
In case of type-1 transmembrane proteins, intracellular proteolysis is catalyzed by the 
ϒ-secretase complex. The ϒ-secretase is comprised of minimal four proteins that are 
essential for its proteolytic activity (De Strooper et al., 2003). While Presenilin 1 or 
presenilin 2 (PS1 and PS2) is the core catalytic unit of the ϒ-secretase complex, 
Nicastrin (NCT), anterior pharynx defective 1(APH-1), and presenilin enhancer 2 (PEN-
2) are the three other cofactors for active ϒ-secretase-mediated proteolysis (Goutte et 
al., 2002, Kimberly et al., 2003, Edbauer et al., 2003). The four proteins stabilize each 
other post-assembly and are required for proper trafficking of the mature complex to the 
cell surface or to the endocytic compartments where the ϒ-secretase exerts its effect.  
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Fig 1.5. Mechanistic principle of Regulated Intramembrane Proteolysis (RIP) (Taken from Müller et 
al., 2016) 
1.7.2. Activity-dependent cleavage of neuronal proteins  
Regulated intramembrane proteolysis is an elegant cellular mechanism for fine-tuning 
extracellular cues with intracellular signal transduction, and thus could be an excellent 
mechanism of choice when it comes to activity-dependent information transmission. 
There is growing evidence of RIP occurring in the nervous system, and often the 
released ICDs play a significant role in gene regulation, cell maturation, apoptosis and 
synapse formation in CNS. The following table (Table 1.2) contains a list of emerging 
and characterized neuronal proteins that undergo RIP. Their ICDs has been found to 
play a predominant role in controlling and orchestrating cellular processes in the brain.  
1.7.3. NG2 is a type-1 transmembrane protein that undergoes proteolytic cleavage 
NG2 (CSPG4) is a type-1 transmembrane protein (300 kD MW), belonging to the 
chondroitin sulfate proteoglycan protein family with a large extracellular region (290 kD, 
consisting of 2200 aa) and a very short intracellular domain (8.5 kD, composed of 77 
aa). It was first discovered in the rat nervous system (Stallcup, 1977) and has reported 
homologs in mouse (Niehaus et al., 1999; Schneider et al., 2001; Stegmuller et al., 
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2002), human (Pluschke et al., 1996) and Drosophila (Estrada et al., 2007; Schnorrer et 
al., 2007).  
 
Table 2. Proteolytic cleavage of neuronal type-1 membrane proteins  
 
 
Name of the Protein The function of released ICDs References 
Notch 1. Involved in nuclear signaling  
2. Inhibits neurogenesis and 
promotes gliogenesis. 
Zhou et al., 2010, 
Andersson et al., 2011. 
APP 1. Exerts transcriptional activity.  
2. Regulates cytoskeleton 
reorganization.   
3. Regulates neuronal growth, and 
apoptosis. 
Kawasumi et al., 2004, Raychaudhuri 
and Mukhopadhyay, 2011, Muller et 
al., 2008. 
Neuregulin 1 1. Prevents neuronal apoptosis. 
2. Positively regulates neuronal 
survival.  
Bao et al., 2003, 
Wolpowitz et al., 2000. 
p75NTR 1. Facilitates TrkA-dependent neurite 
outgrowth. 
2. Crosstalk with Erk1/2 signaling. 
Forsyth et al., et al., 2014 
Ceni et al., 2010. 
L1CAM 1. Downregulates PTEN and p53, 
causing increased neuritogenesis.  
2. Regulates gene expression of 
Cathepsin, integrins, and HOXA9. 
Wang et al., 2015., 
Riedle S et al.,  2009. 
 
ErbB4 1. Together with TAB2 and N-CoR, 
ErbB4-ICD represses expression of 
genes associated with neuronal 
precursor cell differentiation.  
2. Plays a role in NRG1-induced 
oligodendrocyte maturation and cell 
death. 
Lal M et al., 2011, 
Sardi et al., 2006. 
N-cadherin 1. Nuclear translocation along with 
bound catenin and upregulates EMT 
effector genes such as catenin or 
cyclin D1. 
 
Marambaud et al., 2003 
VR Rao et al., 2003 
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The extracellular region of NG2 is heavily glycosylated and contains one confirmed 
glycosaminoglycan (GAG) chain with several predicted N-glycosylation motifs 
(Nishiyama et al., 1991). The extracellular part also harbors two conserved Laminin 
Neurexin Sex-hormone binding (LNS) domain N-terminally, which show similarity with 
the LNS domain of neuronal synaptic adhesion proteins, the Neurexins. No interaction 
partner for the NG2 LNS domain has been reported so far. (Sakry et al., 2015). (Fig 1.6) 
The large extracellular domain of NG2 protein includes cleavage site proximal to the 
membrane (Nishiyama, 2009) and undergoes sequential cleavage mediated by α-
secretase and ϒ-secretase resembling a common cellular event known as Regulated 
Intramembrane Proteolysis (RIP). It has been shown that ADAM10 is the major 
catalyzing α-secretase for NG2 ectodomain shedding, similar to the cleavage pattern of 
Notch, generating a 290 kD ectodomain and a 12 kD membrane-bound C-terminal 
fragment (CTF), the latter is found in a higher level in membrane fractions. It has been 
demonstrated by inhibiting ϒ-secretase function that the NG2 CTF is subjected to 
constitutive cleavage by the ϒ-secretase yielding an intracellular fragment of the NG2 
protein (Sakry et al., 2014). NG2 ICD is defined as a proteolytically cleaved and 
released intracellular part of the NG2 protein in analogy to the ICDs of NOTCH or APP. 
This peptide-sequence is an element of the intracellular region of the full-length protein 
or the CTF. 
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Fig 1.6. Diagrammatic representation of NG2 protein (Taken from Trotter et al., 2010) 
1.7.4. Structure and function of NG2 ICD  
The small C-terminal part of the NG2 protein consists of 77 amino acids and 8.5 kD 
(MW). This intracellular domain (ICD) is a product of γ-secretase action on full-length 
NG2 and it harbors several predicted protein binding motifs (ELM database) including 
MAPK binding motif (6-14 aa), WW4 motif (62-67 aa), PDZ2 binding motif (72-77 aa), 
PTB-Phospho domain-binding motif (69-75 aa) and two monopartite classical Nuclear 
localization signals (NLS; 1-7 aa).  To date, the study of phosphorylation in the 
intracellular region of the NG2 protein and the identification of intracellular binding 
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partners of NG2 has been done mainly on membrane-bound CTF of NG2 (table 1.3). 
However, it is still not known if NG2 intracellular domain exerts any distinct functional 
properties of its own after its release into the cytosol.  
A                                                                         B                                                                                                                                                                                                             
 
 
 
 
Fig 1.7. (A) Schematic cartoon of the NG2 intracellular region along with predicted motifs. B) predicted 
motifs found in the NG2 intracellular region by ELM motif search database (http://elm.eu.org/).  
Table 3. The intracellular PDZ-binding partners of the NG2 protein 
 
Name of the 
Protein 
Function Reference 
Syntenin-1 Serves as an adapter molecule that connects NG2 to its 
downstream signaling components and especially required for 
cytoskeleton reorganization and migration.  
Chatterjee et al., 
2008, JBC.  
MUPP1 Scaffolding protein associated with the formation of multimeric 
structural and signaling complex.  
Barritt et al., 2000, 
JCB.  
GRIP1 Act as a scaffolding protein and cluster protein complexes at the 
cell surface and serves as a direct molecular link between 
AMPA receptor and NG2 proteoglycan in OPCs.  
Stegmüller et al., 
2003, JBC.   
OMI/Htra2 A serine protease that acts as a chaperone but in stress 
conditions, induce apoptosis. NG2 exerts a protective effect on 
OPCs by binding and sequestering OPCs.  
Maus et al., 2015, 
PLOS One.  
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2. Aim of the study 
As previously discussed, growing evidence suggests the involvement of RIP in 
regulating neuronal network function and architecture. Since NG2 also undergoes RIP 
and releases an intracellular cleavage product, it is important to characterize the 
cleaved product and potential intracellular binding partners in order to clarify a possible 
biological role. This project aimed to investigate the subcellular localization pattern and 
function of cleaved NG2 ICD after its release into the cytosol. With a combination of 
various NG2 expression constructs and Mass-spectrometry based proteomics study 
along with high-resolution microscopy and molecular biology tools, the questions 
mentioned above have been addressed in this study.  
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3. Materials and Methods 
3.1.1. Equipment 
 
Table 4. Device and Equipment 
 
 
 
 
Device Type Manufacturer   
Cell culture Equipments 
 
Sterile working bench   The Baker Company 
CO2 incubator Labotect, Sanyo 
Centrifuge Megafuge® 1.0R Heraeus 
Inverted microscope Leica 
 Water bath  Hermle   
Microscope 
 
DM6000 Leica, Wetzler 
TCS SP5 Leica, Wetzler 
DMLB Leica, Wetzler   
Transfection device 
 
AMAXA Nucleofector II Lonza 
GenePulser Xcell BioRad, München   
PCR machine 
 
Real-Time PCR System Applied Biosciences 
PCR Thermocycler Biometra   
Other lab equipments 
 
Bacteria incubator Noctua 
Luminometer (Infinite M200 Pro Tecan 
Tabletop Biofuge® fresco Heraeus 
Magnetic separation device Invitrogen 
Heating thermomixer HLC, Bovenden 
NuPAGE western blotting system Invitrogen 
NanoDrop 1000 Spectrophotometer Peqlab 
Optimax Type TR X-Ray Film processor MS Laborgeräte 
Scanner Epson 
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3.1.2.  Materials 
Table 5. Chemicals and Reagents 
Name Cat. No Source 
96-well Plates white (Luminescence) #236105 Nunc 
anti-flag M2 dynabeads #M8823 Sigma 
Anisomycin #A9789 Sigma 
Agarose (low melt) #6351.2 Roth 
BrdU (5-Bromo-2´-Deoxyuridine) #B23151 Life Technologies 
Benzonase, Purity>90% #70746-4 Merck Millipore 
BSA Nuclease-free 10% #126615  Calbiochem 
Chloroform #3313.1 Roth 
DAPI  #D9542  Sigma Aldrich 
DMEM #D5796 Sigma 
Dynabeads Protein G #10004D Life Technologies 
EDTA  #8040.2  Roth 
Ethanol #9065.4 Roth 
FuGENE HD transfection reagent #E2311 Promega 
H2O Ultrapure  #W4502  Sigma Aldrich 
Halt Protease Inhibitor Cocktail #1860932 Thermo Fisher 
Ivermectin #I8898 Sigma 
MG-132, proteasome inhibitor, ≥90% (HPLC) #M7449 Sigma 
Magnesium chloride #M2670 Sigma Aldrich 
MicroAmp® 48-Well Optical Adhesive Film #4375323 Life Technologies 
MicroAmp® Fast Optical 48-Well Reaction Plate #4375816 Life Technologies 
Mowiol 4-88 reagent #475904 Calbiochem 
NE-PER Nuclear/Cytoplasmic Extraction Kit #78833 Pierce 
Nonidet™ P 40 Substitute  #74385  Fluka 
NuPAGE® LDS Sample Buffer (4x) #NP0007  Life technologies 
Invitrogen NuPAGE® MES SDS Running Buffer (20X)  #NP0002  Life technologies 
NuPAGE® MOPS SDS Running Buffer (20X) #NP0001  Life technologies 
NuPAGE® Novex® 4-12% Bis-Tris Protein Gels   #NP0335BOX Life technologies  
O´GeneRuler 1kb DNA Ladder #SM1163 Thermo Scientific 
PFU Turbo DNA Polymerase #600250 Stratagene 
Puromycin dihydrochloride #P8833 Sigma 
Propidium iodide #P4176 Sigma 
Ponceau S solution #P7170 Sigma 
Propanol ROTIPURAN®  #6752.2  Roth 
QIAzol Lysis Reagent #79306 Qiagen 
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RNase A  #12091-039  Invitrogen 
RNase-free DNase Set #79254 Qiagen 
 RNaseZAP  #R2020  Sigma Aldrich 
RNasin® Plus RNase Inhibitor #N2611 Promega 
 Roti®-Histofix  #P087.3  Roth 
Sodium butyrate #30341-0 Sigma Aldrich 
Sodium chloride  #S3014  Sigma Aldrich 
TaqMan® Gene Expression Master Mix  #4369016  Life Technologies 
Tris #4855.1 Roth 
Triton X-100  #3.051 Roth 
Tween 20 #9127.2 Roth  
Kit name Cat No Manufacturer 
PureLink HiPure Plasmid Miniprep kit #K210011 Invitrogen 
PureLink HiPure Plasmid Maxiprep kit #K2100-07 Invitrogen 
QIAquick Gel Extraction Kit #28706 Qiagen 
QIAquick PCR Purification Kit #28106 Qiagen 
Basic Primary neurons Nucleofector kit #VPI-1003 Lonza 
Transcriptor First Strand cDNA Synthesis Kit #04896866001                 Roche 
BCA Protein Assay Kit  Merck Millipore 71285-3 
Direct-zol™ RNA MiniPrep Plus Zymo Research R2070 
TaqMan® Universal Master Mix II, with UNG Life Technologies (Thermo 
Scientific™) 
4440042 
SensiFAST Probe Hi-ROX Kit (Lot.B018180) Bioline BIO-82002/S 
 
3.1.3 Reagents 
Table 6. Buffers and Medium 
Buffer/Medium/Solution Composition   
10 x Poly-L-Lysine (PLL)  0.1 % PLL (Sigma, #P1524) in ddH2O   
Sato 1.0-1.5 % HS (Oli-neu 
culture medium) 
13.4 g/l DMEM (Invitrogen, #52100-039), 2 g/l NaHCO3, 0.01 g/l 
transferrin, 100 μg/l insulin, 100 μM putrescine  
 200 nM progesterone, 500 nM TIT, 220 nM Sodium-selenite, 520 mM L-
thyroxine, 1.0-1.5% (v/v) horse serum   
  
SILAC light medium (modified 
SATO) 
SILAC-DMEM (Life technologies, 89985), 2 g/l NaHCO3, 0.01 g/l 
transferrin, 100 μg/l insulin,    
100 μM putrescine, 200 nM progesterone, 500 nM TIT, 220 nM Sodium-
selenite, 520 mM L-thyroxine,  
4 mM L-Glutamine, 1% (v/v) horse serum, 146 mg/ml Lysine-0 (Sigma-
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Aldrich L8662),   
84 mg/ml L-Arginine-0 (Sigma-Aldrich, A6969)   
SILAC Medium-heavy medium 
(modified SATO) 
SILAC-DMEM (Life technologies, 89985), 2 g/l NaHCO3, 0.01 g/l 
transferrin, 100 μg/l insulin,    
100 μM putrescine, 200 nM progesterone, 500 nM TIT, 220 nM Sodium-
selenite, 520 mM L-thyroxine,  
4 mM L-Glutamine, 1% (v/v) horse serum, 146 mg/ml Lysine-4 
(Cambridge Isotope laboratories, DLM-2640-PK),   
84 mg/ml L-Arginine-6 (Cambridge Isotope laboratories, CLM-2265-H-1)   
SILAC heavy medium (modified 
SATO) 
SILAC-DMEM (Life technologies, 89985), 2 g/l NaHCO3, 0.01 g/l 
transferrin, 100 μg/l insulin,    
100 μM putrescine, 200 nM progesterone, 500 nM TIT, 220 nM Sodium-
selenite, 520 mM L-thyroxine,  
4 mM L-Glutamine, 1% (v/v) horse serum, 146 mg/ml Lysine-8 
(Cambridge Isotope laboratories, CNLM-291-H-1),   
84 mg/ml L-Arginine-6 (Cambridge Isotope laboratories, CNLM-539-H-1)   
HEK Culture medium Dulbecco’s Modified Eagle’s Medium - high glucose (Sigma, D5796), 10% 
FCS, 1% sodium pyruvate   
DMEM-SILAC light medium  SILAC-DMEM (Life technologies, 89985), 10% Dialyzed FBS (Sigma-aldrich, 
F0392), 1% Penicillin/Streptomycin,  
146 mg/ml Lysine-0 (Sigma-Aldrich L8662), 84 mg/ml L-Arginine-0 (Sigma-
Aldrich, A6969)   
DMEM-SILAC Medium-heavy 
medium  
SILAC-DMEM (Life technologies, 89985), 10% Dialyzed FBS (Sigma-aldrich, 
F0392), 1% Penicillin/Streptomycin,  
146 mg/ml Lysine-4 (Cambridge Isotope laboratories, DLM-2640-PK),84 
mg/ml L-Arginine-6 (CIL, CLM-2265-H-1)   
DMEM-SILAC Heavy medium  SILAC-DMEM (Life technologies, 89985), 10% Dialyzed FBS (Sigma-aldrich, 
F0392), 1% Penicillin/Streptomycin,  
146 mg/ml Lysine-8 (CIL, CNLM-291-H-1), 84 mg/ml L-Arginine-6 (CIL, 
CNLM-539-H-1)   
Trypsin/EDTA „low“ 0.01% trypsin, 0.02% EDTA in HBSS   
Freezing medium 20% (v/v) FCS, 10% (v/v) DMSO in RPMI 1640   
LB medium 10 g trypton, 5 g yeast extract, 10 g NaCl, fill to 1000 ml with ddH2O, 
pH=7.4   
LB agar  4.5 g agar-agar in 300 ml LB medium   
Methods 
 
36 | P a g e  
 
SDS running buffer for 
electrophoresis (5x)  
125 mM Tris, 1.25 M glycine, 0.5 % (w/v) SDS, pH=8.3 
  
Western blot transfer buffer 24 mM Tris, 192 mM glycine, 20% ethanol in dH2O   
 WB blocking buffer  4 % (w/v) dry milk/BSA powder in PBST   
PBS 150 mM NaCl, 8 mM Na2HPO4, 1.7 mM NaH2PO4, pH=7.2   
PBST 0.1% (v/v) Tween 20 in PBS   
Homemade ECL solution Solution A: 50 mg luminol in 200 ml 0.1 M Tris-HCl pH=8.6, Solution B: 11 
mg para-hydroxy coumaric acid in   
10 ml DMSO (dark), ECL solution: combine 1 ml solution A + 100 μl 
solution B + 0.3 μl H2O2   
DAPI stain 1 μg/μl DAPI (#D9542, Sigma) in PBS   
Mounting medium 2.4 g moviol 4-88, 6 g glycerol, 6 ml ddH2O, 12 ml 0.2 M Tris pH=8.5   
4x sample buffer 200 mM Tris-HCL, pH=6.8, 10% (w/v) SDS, 0.4% (w/v) bromphenol blue, 
40% (v/v) glycerol, 400 mM DTT   
Post-nuclear cell lysis buffer 1X PBS, 1% Tx-100, 1X Protease inhibitor cocktail.   
Nuclear lysis buffer 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM MgCl2, 1% TX-100, 2.5 
mM Beta-glycerophosphate,  
1 mM NaF, 1 mM DTT, 2mM EDTA, 10% glycerol 10 unit of Benzonase, 1X 
Protease inhibitor cocktail.    
Permeabilization buffer 1X PBS, 0.1%-0.5% TX-100   
Fixation solution 1x PBS, 4% paraformaldehyde or 1:1 acetone:methanol   
Blocking solution 1X PBS, 10% Horse serum. 
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3.1.4. Antibodies 
Table 7. List of primary antibodies (IB: Immunoblot, IF: Immunofluorescence, FC: Flow 
cytometry) 
 
Table 8. List of secondary antibodies 
 
Antigen Cat No Host 
species 
Application with 
dilution  
Manufacturer 
Flag M2 F1804 Mouse IB (1:1000), IF (1:400) Sigma 
Flag-FITC M2 F4049 Mouse FC (1: 200) Sigma 
Lamin B ab16048 rabbit IB (1:1000), IF (1:500) Abcam 
Eef2 ab40812 rabbit IB (1:1000) Abcam 
Eif4b 3592 T rabbit IB (1:1000) NEB(CST) 
FMRP F4055 rabbit IB (1:1000) Sigma 
Cofilin #612144 Mouse IB (1:1000) BD Transduction 
GAPDH A-300-641A rabbit IB (1:5000) Biomol 
Tubulin T9026 mouse IB (1:5000) Sigma 
PCNA 13110T rabbit IF (1:250) NEB(CST) 
p70S6K1 9202S rabbit IB (1: 1000) NEB(CST) 
mTOR substrate antibody 
sampler kit 
9862T rabbit IB (1:1000) NEB(CST) 
phospho-eif4b (Ser422) 3591T rabbit IB (1:800) NEB(CST) 
ADNP2 WA-
AP13981 
rabbit IB (1:1000) Biomol 
AGAP2 NBP2-24498 rabbit IB (1: 1000) Novus Biological 
Puromycin MABE343 Mouse IB (1:1000) Merck Millipore 
Cyclin E SC-377100 Mouse IB (1:400) Santa Cruz 
NG2  Rat IB (1:200), IF(1:100) Hybridoma 
Culture 
supernatant 
NG2-Cyto  Rabbit IB (1:200) AG Trotter 
Host species Target species  Conjugation   Application  Manufacturer 
goat  mouse HRP   1:10000  Dianova 
goat  rat  HRP  1:10000  Dianova 
goat  rabbit  HRP  1:10000  Dianova 
goat  mouse  Alexa488  1:400  Invitrogen 
goat  rabbit  Cy3 1:800  Dianova 
donkey mouse  Alexa546 1:400  Invitrogen 
Methods 
 
38 | P a g e  
 
3.1.5 Software 
Table 9. List of used software 
 
3.2. Cell biology 
3.2.1. Cell culture 
3.2.1.1. Oli-neu Cell Culture 
The oligodendrocyte precursor cell line Oli-neu was generated from primary mouse 
OPCs by transferring the t-neu oncogene using replication deficient retroviruses. t-neu 
is expressed under the control of the thymidine kinase promoter in Oli-neu cells and 
maintains the proliferative state of the cells (Jung et al., 1995). Oli-neu cells were 
cultured on 1X PLL coated culture dishes in Sato + 1.5 % HS medium with 8% CO2. For 
passaging, cells were detached after incubation with pre-warmed trypsin/EDTA for 2 
min. Reaction was stopped by adding the same amount of PBS + 10 % HS (4 °C) and 
cells were centrifuged at 800 rpm at 4 °C for 10 min. To freeze cells for long-term 
storage, cell pellet was resuspended in freezing medium at – 80 °C and stored in liquid 
nitrogen.  
 
 
Software Resource 
Microsoft Office 2013 Microsfot  
FunRich proteomics analysis tool FunRich 
Pathways analysis by ontology DAVID (NIH) 
StepOne Software 2.2.2 Applied Biosystem 
Endnote X5 Thomson Reuters 
ImageJ Open source, NIH 
Clone Manager 9 Professional Sci-Ed Software 
LAS AF Microscope Software Leica 
GraphPad Prism 
Flowjo BD company 
MaxQuant Max Planck Institute of Biochemistry 
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3.2.1.2. HEK293T Cell Culture 
HEK293T cells derive from human embryonic kidney cells and were cultured in DMEM 
+ 10 % FCS in non-coated culture dishes with 5% CO2. Passaging and freezing 
procedure was like the protocol used for Oli-neu cells. 
3.2.1.3. Primary OPCs isolation and maintenance 
For primary OPC (pOPC), single cell suspensions were obtained from total brains of the 
Postnatal day (P) P6-9 of C57Bl/6N mice using the NTDK-P Kit (Miltenyi Biotec). 
Magnetic isolation (MACS) was performed as described previously (Diers-Fenger et al., 
2001). 300,000 cells were plated in each well of a PLL-coated dish (6-well format) and 
cultured in OPC proliferation medium. OPC proliferation medium consists of 
NeuroMACS medium (Miltenyi) supplemented with 1:50 of NeuroBrew Miltenyi, 1:100 of 
L-Glutamine, 1:100 Pen-strep and 1:1000 of stock conc. of each of Forskolin (4.2 
mg/ml), CNTF (10 µg/ml), PDGF (10 µg/ml) and NT-3 (1µg/ml). pOPCs were 
maintained at 37°C with 8%CO 
3.2.2 Transfection methods 
3.2.2.1. FuGENE HD transfection of plasmid DNA  
 
Oli-neu cells were transfected with plasmid DNA chemically by FuGENE HD (Promega) 
according to the manufacturer’s instructions. Generally, 90-100 x 103 cells were seeded 
into 6-well plate the day before transfection. 2 μg of DNA were diluted in 100 μl pre-
warmed DMEM (without serum) and combined with 6 μl FuGENE HD (1:3 ratio). 
Transfection complexes were mixed and incubated for 10 mins before applying to the 
cells. Cells were analyzed 24-72 hours after transfection. The amount of plasmid DNA 
and FuGENE reagent were scaled up according to the used cell-culture dish diameter 
and cell number with a constant transfection ratio.  
 
3.2.2.2. PEI transfection 
 
HEK293 cells were transfected chemically using PEI reagent. One day prior 
transfection, 0.5×106 cells were seeded in 6-well plate format. For transfecting cells in a 
3 cm dish, in a sterile tube, 2 µg of plasmid DNA was diluted with serum-free, pre-
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warmed DMEM and 6 µl of PEI (1 µg/µl) and mixed immediately. After 15 mins 
incubation at RT, the mixture was applied to cells and after 48 hours of transfection, 
cells were analyzed. 12 hours after transfection, cells were checked and if needed, the 
medium was replaced with fresh batch.  
 
3.2.2.3. Bio-Rad GenePulser electroporation 
 
Cells were transfected with plasmids using the Bio-Rad GenePulser Xcell. 1.5 – 2.0 x 
106 cells in 600 μl were transferred to a 4 mm electroporation cuvette containing 8 μg 
DNA followed by thorough mixing. The cuvette containing the cells was attached to the 
GenePulser device for pulsing (exponential decay program; 220 V, 950 μF) followed by 
an incubation time of 5 min at RT. Cells were plated on a 6cm culture dish. After 4 – 6 h 
medium was changed with fresh batch of medium.  
 
3.2.2.4. Amaxa nucleofection of siRNA  
 
RNAi was used to knockdown expression of selected target genes from Oli-neu cells 
using the Amaxa Basic Nucleofector® Kit for Primary Neurons according to the 
manufacturers’ instructions. 1 x 106 Oli-neu cells were pelleted at 100 g at room 
temperature, resuspended in 100 μl AMAXA solution and combined with 160 pmol of 
siRNA. Electroporation was carried out using program O-005 in the AMAXA 
Nucleofector II device, the cell suspension in the electroporation cuvette was 
immediately combined with the warm, CO2-equlibrated plating medium and then 
carefully seeded in PLL-coated cell culture dishes. Culture medium was exchanged 4-5 
hours post nucleofection and cells were analyzed 24-72 hours later. 
3.2.3. FACS 
Cells were plated in 100 mm dishes and chemically transfected with flag-tagged 
constructs (BAP-Flag and ICD-Flag) one day after plating. After 48 hours post-
transfection, cells were trypsinized and pelleted down (800 rpm, 10 mins). Cells were 
washed with PBS two times to remove residual medium and resuspended in PBS for 
counting. Equal number of cells were taken into a glass tube from each condition and  
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Fig 3.1. Gating strategy for cell-cycle distribution analysis in FITC+ cells only 
 
cells were fixed with pre-chilled 80% ethanol (1:3 volume ratio) in a dropwise manner 
while low-vortexing the tubes and put on ice for 30 minutes. Fixed cells were washed 
two times with PBS and then permeabilized with permeabilization buffer (1XPBS, 0.1% 
TX-100) for 15 minutes at RT. Primary antibody (Flag-FITC, 1 µg of antibody taken for 1 
million cells) was diluted in permeabilization buffer and cells were incubated with 
primary antibody solution for 2 hours at RT in dark. Afterwards, cells were washed two 
times with PBST and RNAse A (final conc; 10 µg/mL) was immediately added. 
Propidium Iodide (PI) was added for staining DNA at a final concentration of 50 µg/mL 
and the cells were incubated in dark for 30 mins on ice. Untransfected cells were taken 
as a negative control for assessing Flag-FITC background staining and incubated in 
similar fashion with PI and RNAse A before subjecting to FACS analysis.  BD FACSAria 
and LSRFortessa were used for cell sorting and cell-cycle analysis. The gating strategy 
was chosen in a manner so that only Flag-transfectants were sorted for DNA content 
analysis.  
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3.3. Molecular Biology 
3.3.1. DNA analysis and manipulation 
 
3.3.1.1. Polymerase chain reaction (PCR) 
 
Polymerase chain reaction (PCR) was used to amplify DNA fragments from plasmid 
DNA according to the following PCR set-up program below. Recognition sequences 
specific to restriction enzymes were included into designed primer pairs and are 
summarized in table X. Reaction conditions mainly varied in annealing temperature 
(primer-dependent) or the duration of elongation step (depends on amplicon’s length).   
 
Table 10. List of primers and restriction sites used for PCR 
 
Table 11. PCR Components 
Component Amount 
DNA template 50 ng 
Forward Primer (10 µM) 2 µl 
Reverse PRIMER (10 µM) 2 µl 
DNTPs mix 4 µl 
reaction buffer (10X) 5 µl 
Pfu polymerase 1 µl 
nuclease free DDH2O fill to 50 µl 
 
Target 
sequence 
Forward primer  Reverse primer  Used 
Restriction 
enzyme  
NG2 DEL ATATCTAGAATGCTTCTCGGCCCGGGACA ATAGGATCCCCCACCCAGTACT XbaI(Fwd), 
BamhI(Rev) 
NG2 ICD 
(2251-2327 
aa) 
ATATCTAGAATGCTCCGCAAACGCAACAAG
AC 
ATAGGATCCCCCACCCAGTAC XbaI(Fwd), 
BamhI(Rev) 
NG2ICDΔNL
S 
(2259-2327 
aa) 
ATAGAATTCATGCACGATGTCCAGGT GCTTTCTAGATCCCACCCAGTA
CT 
EcorI(Fwd), 
XbaI(Rev) 
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Table 12. PCR Cycler Program 
After final extension of 10 min, samples were cooled to 4°C and subsequently analyzed 
or stored at -20°C for further use.  
3.3.1.2. DNA purification and analysis  
 
The QIAquick® PCR Purification Kit (Qiagen) was used according to manufacturer’s 
protocol and DNA was eluted with nuclease-free H2O. Concentration of the eluted DNA 
samples were determined with the Nanodrop® 1000 photospectrometer (Thermo 
Scientific) and subsequently PCR products were analyzed by agarose gel 
electrophoresis. 
3.3.1.3. Agarose gel electrophoresis 
 
According to the DNA product size, 1-2% Agarose gels were prepared fresh in 1x TAE 
Buffer by dissolving the agarose in a microwave. After cooling it down, 0.01% Ethidium 
Bromide was added, and the gel was poured into a horizontal gel chamber to solidify. 
The samples were mixed with 6x Loading dye (Fermentas), loaded on the gels and ran 
together in 1X TAE buffer with the Gene ruler 1 kb DNA ladder (Fermentas) until 
desired separation was achieved. Afterwards, images of the gels were taken and 
printed with a UV-based gel documentation system.  
 
3.3.1.4. DNA extraction from agarose gel 
 
The corresponding DNA fragments were excised from the gel with a clean razor blade 
and the DNA was isolated using the QIAquick Gel Extraction Kit (Qiagen) according to 
the manufacturer´s instructions.  
 
Function Temperature Time Step 
Initial denaturation   95°C  1-2 min 1 
Denaturation 95°C 30 secs 2 
Primer annealing   60-65°C 30 secs  3 
Extension 72°C 1 min / kb 4, go to Step 2 (19x- 35x) 
 Final extension  72°C  10 min 5 
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3.3.1.5. Restriction enzyme digestion 
Restriction enzyme digestion (purchased from NEB) were done according to 
Manufacturer’s protocol. Volume and amounts were varied depending on whether a 
single or double digestion was being performed. The total volume was finally filled with 
ddH2O up to 50μl.  
 
3.3.1.6. Ligation and transformation  
Ligation of DNA inserts with the chosen vector backbone was carried out using the T4 
DNA Ligase (Promega) according to the manufacturer’s instruction. Ligation products 
were amplified in transformation competent TOP10F’ Escherichia coli cells (Invitrogen). 
For transformation of TOP10F’ cells, after thawing, 50 μl cell suspension was taken and 
mixed with 10 μl of ligation product. The mixture was kept on ice for 30 min and 
subjected to heat-shock at 42°C for one minute. After adding 500 μl of pre-warmed, 
antibiotic-free LB medium, cells were incubated for 30 min at 37°C before an 
appropriate volume was spread on antibiotic-containing LB-Agar plates. The agar plates 
were incubated overnight at 37°C in a bacterial incubator and single colonies were 
selected for plasmid amplification and preparation. 
3.3.1.7. Plasmid preparation 
For Miniprep cultures, individual bacterial colonies from the agar plates were picked and 
incubated in 4 ml LB medium containing selected antibiotics on a shaker at 37°C for 
overnight. Plasmid preparation from transformed bacteria cultures was performed using 
the PureLink™ Quick Plasmid Miniprep Kit (Invitrogen). Pelleted plasmid was extracted 
from the column with 30 μl of ddH2O.  
To set up Maxiprep cultures, 100 μl of Miniprep culture or a filter tip covered with 
bacterial glycerol stocks were added to 300 ml of LB medium containing suitable 
antibiotics. Cultures were incubated overnight at 37°C in a shaking bacterial incubator. 
Plasmid DNA was extracted using PureLink™ HiPure Plasmid Maxiprep Kit (Invitrogen) 
according the manufacturers’ protocols. Plasmid DNA was eluted with 200 μl ddH2O 
and concentration was measured using Nanodrop and afterwards stored in -20°C for 
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further use. The following NG2 expression constructs were created with the p3X-Flag-
CMV-14 (Sigma) vector backbone. 
 
 
 
 
 
 
 
 
 
 
Fig 3.2. Diagrammatic representation of NG2 expression constructs used in the study 
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3.3.2. RNA analysis 
3.3.2.1. Isolation of total RNA from cultured cells  
 
Oli-neu cells were washed with cold PBS and directly lysed with 700 µl QIAzol Lysis 
reagent, vortexed for 15 seconds and stored at -80°C. Total RNA was extracted with the 
miRNeasy® Mini Kit (Qiagen) according to the manufacturer’s instructions, including 
DNase digestion using the RNase-free DNase Kit (Qiagen). 30 µl of nuclease-free water 
was used to elute RNA from the column, concentration was determined using 
Nanodrop® 1000 and samples were stored at -80°C immediately or used for cDNA 
synthesis. 
 
3.3.2.2. Reverse transcription cDNA synthesis  
 
cDNA was synthesized by using the Transcriptor First Strand cDNA Synthesis Kit 
(Roche) according to the manufacturer’s instructions with minor modifications. Initially, 
100 ng of RNA and 2 µl of random hexamer primers were mixed and heated for 10 min 
at 65°C and immediately placed on ice. The RT master mix, including 5U of Transcriptor 
Reverse Transcriptase was added and RT reaction was performed according to Table 
13 in a thermal cycler, yielding cDNA libraries directly used in quantitative real time PCR 
or normal PCR reactions. 
 
Table 13. RT-PCR set up 
 
 
 
 
Component Amount 
RNA template 100 ng 
RT master mix  4 µl 
dNTP mix 2 µl 
Reverse Transcriptase 0.5 µl 
RNAsin 0.5 µl 
Random hexamer primers 2 µl 
nuclease free ddH2O fill upto 20 µl 
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3.3.2.3. Quantitative PCR (qPCR) 
The cDNA libraries were analyzed with gene specific Taqman® Gene Expression 
Assays (Table 15) using the Taqman® Gene Expression Master Mix (Applied 
Biosystems) according to the manufactures’ instructions and a total reaction volume of 
10 µl. In each reaction, 1.0 µl cDNA was used and samples were run in duplicate or 
triplicate on a StepOne™ Real-Time PCR system following the mentioned cycler 
program. In no template-controls (NTC) cDNA was replaced by nuclease-free water. 
Relative gene expression was calculated by the ΔΔCt method with the StepOne 
Software 2.2.2 using Pgk1 or Gapdh as a reference gene. 
 
Table 14. RT-PCR Program 
Step Temparature Time 
Annealing 25°C 10 min 
Reverse Transcription 55°C 30 min 
RT Enzyme deactivation 85°C 5 min 
Storage 4°C End 
 
Table 15. Taqman Gene expression assays 
Target gene Catalogue number Source 
Eef2 Mm01171435_gH  Applied Biosystems 
Fmr1 Mm01339582_m1 Applied Biosystems 
Mbp  Mm01262037_m1 Applied Biosystems 
Pgk1 Mm00435617_m1 Applied Biosystems 
Dlg4 (PSD-95) Mm00492193_m1  Applied Biosystems 
Gapdh Mm99999915_g1 Applied Biosystems 
 
3.3.2.4. mRNA stability assay 
For studying mRNA stability, Oli-neu cells were grown in 6 cm culture dishes one day 
prior transfection. 48 hours post-transfection with NG2 ICD and control expression 
constructs, cells were treated with a transcription blocker, DRB (5,6 
Dichlorobenzimidazole 1-β-D ribofuranoside). DRB was dissolved in ethanol and used 
at a final concentration of 100µM. The optimal timepoint of DRB treatment was first 
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established and subsequently cells were harvested and collected for RNA extraction 
and analysis followed by qPCR as described above.  
3.4. Protein Biochemistry 
3.4.1. Cell lysis 
For preparing post-nuclear (PN) lysate, cells were washed twice with cold 1x PBS 
before being scraped off on ice in cold triton lysis buffer (4 °C) containing Complete 
Protease Inhibitor Cocktail (Roche) using a rubber policeman. Lysates were incubated 
on a rotor at 4 °C for 20-30 min and subsequently centrifuged (1000 x g, 4 °C, 10 min) 
to remove cellular debris and nuclei. Lysates were immediately used or stored at – 20 
°C. If needed, protein concentrations were determined with BCA protein Assay Kit 
(Novagen) according to the “Enhanced Assay” protocol. 
For subcellular fractionation assay, cells were washed (1X PBS) and scraped off with a 
rubber policeman on ice and directly lysed on dish with ice-cold cytosolic lysis buffer (1X 
PBS+ 1% NP-40, 1X Protease inhibitor cocktail). Lysates were incubated on a rotor at 4 
°C for 20-30 min and subsequently centrifuged (2000 x g, 4 °C, 10 min). Supernatants 
enriched with cytosolic fraction was collected and the pelleted nuclei was digested with 
nuclear lysis buffer (20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM MgCl2, 1% TX-
100, 2.5 mM Beta-glycerophosphate, 1 mM NaF, 1 mM DTT, 2mM EDTA, 10% glycerol 
10 unit of Benzonase, 1X Protease inhibitor cocktail.) for 1 hour on rotor at 4 °C for 40-
60 min with occasional mixing. Samples were centrifuged at 7000 g for 10 mins and 
supernatant was collected which comprises of nuclear proteins.  
3.4.2. SDS-PAGE and Western blotting 
Proteins were separated according to size by Sodium Dodecyl Sulfate Polyacrylamide 
Gel Electrophoresis (SDS-PAGE). Novex® NuPAGE® SDS-PAGE Gel system 
(Invitrogen) using 4-12% Bis-Tris gradient gels with MOPS or MES running buffer was 
used for this purpose. Protein lysates were diluted in appropriate volumes of 4X sample 
buffer and heated to 90°C for 5 minutes prior loading into the gel wells next to 5-10 µl of 
the Precision Plus Protein Standard (Bio-Rad). Electrophoresis was performed at 
constant 150V until the desired separation achieved. Proteins were transferred from the 
Methods 
 
49 | P a g e  
 
gel on a polyvinylidene fluoride (PVDF) membrane (Immobilon-P transfer membrane, 
0.45 μm pore size, Millipore) for 3 hours at 200mA with transfer buffer (see buffer recipe 
table).  
After blotting, membranes were briefly washed in dH2O and incubated in blocking 
solution for at least 30 min to block unspecific antibody binding to the membrane. 
Primary antibodies were applied in blocking solution over night at 4 °C on a shaker. 
Before applying secondary antibodies coupled to horse radish peroxidase (HRP) diluted 
in blocking solution, the membrane was washed three times with PBST for 10 min each. 
After a 30 min incubation time, secondary antibodies were removed, and membrane 
was again washed three times for 10 min each using PBST. Afterwards, proteins were 
visualized on X-Ray films by enhanced chemiluminescence (ECL) reaction using a 
OptiMax X-Ray film processor and subjected to quantitative analysis using the ImageJ 
software. Membranes were dried and kept at – 20 °C for long-term storage.  
For studying the phosphorylated mTOR cascade, for each experiment, same cell lysate 
was used, and the experiment was repeated independently more than three times. Two 
western blots were run in each experiment, one is for the non-phosphorylated protein 
level (example, mTOR) and another is for studying the phospho-specific level (example; 
p-mTOR) as they run on the same molecular weight. First, every studied protein (mTOR 
and p-mTOR) level was normalized to its corresponding loading control (Example; 
GAPDH/tubulin) and then the normalized phospho-protein was divided by normalized 
non-phosphorylated protein level to get the fold-change only specific for the phospho-
epitope.  
3.4.3. Silver and Coomassie staining of the gel 
Before transferring the separated protein on to a blot, gel was stained with Silverquest 
Kit (Invitrogen, LC6070) according to manufacturer’s protocol or with Coomassie 
BrilliantBlue G-250 (SERVA) staining solution according to the instructions. Gel was 
washed with dH2O until the background stain was completely removed and image was 
taken using the Epsion scanner.  
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3.4.4. Immunoprecipitation (IP) 
Cells were transfected with NG2 ICD-Flag or with a positive control protein; Bacterial 
Alkaline phosphatase (BAP)-flag for Flag-pull down assay. After 48 hours of 
transfection, cells were washed, lysed (1x PBS+ 1% TX-100+ 1x protease inhibitor), 
scraped off and incubated on a rotor at 4 °C. Afterwards, cells were centrifuged (3000 g, 
10 mins) and supernatant, enriched with cytosolic proteins were collected. Prior IP, 
protein concentration of the control and ICD-transfected lysate was measured by using 
BCA assay. Generally, 1-1.5 mg of protein was taken for doing IP. Magnetic, pre-
conjugated anti-flag dyna beads (Sigma, M8823) were equilibrated with 1X TBS prior 
use and 60 µl of beads was incubated with pre-cleared (10,000 g, 10 mins, 4 °C) protein 
lysate for 2 hours on a rotor at 4 °C. Afterwards, the beads were washed three times (5 
mins, each wash) with wash buffer (1X TBS, 0.3% Triton-X) by using a magnetic rack 
(Dynamag, Invitrogen) and the immunocomplex was eluted with 80 µl of 2X LDS buffer 
and heated at 80°C for 10 mins. The bead was discarded after separation with magnetic 
rack and the separated lysate containing the immunocomplex was taken in a clean 
eppendorf tube.  IP samples were later used in various experiments including CoIP and 
Mass spectrometry-based analysis.  
3.4.5. SUnSET Assay 
HEK293 and Oli-neu cells were plated 1 day before transfection with different NG2 
expression constructs. 48 hours post-transfection, cells were incubated with puromycin 
(10 µg/mL, diluted in ddH2O) for 15-20 mins in culture medium and immediately lysed 
afterwards directly on culture dish with ice-cold lysis buffer (PBS + 0.5% TX-100 + 1X 
PI). Lysates were run on a 4-12% gradient gel and subjected to western blot analysis. 
Puromycin incorporation was investigated with anti-puromycin antibody. Anisomycin 
was used as a translation blocker (40 µM final conc.) to specify puromycin incorporation 
takes place only in growing nascent polypeptide chains. 
3.5. Immunocytochemistry 
For immunostaining, transfected cells, after reaching desired density, were washed 
three times with 1X PBS to remove residual medium and cell debris and fixed with 
either Roti Histofix 4% paraformaldehyde solution for 15 mins at RT or with pre-chilled 
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100% methanol at -20°C for 10 mins (for PCNA staining). After washing 3 times with 
PBS, cells were transferred into a humified chamber and permeabilized with 0.1%-0.5% 
TX-100 in 1X PBS. After 5 mins, cells were washed again twice with PBS and incubated 
for 30 mins with blocking solution (1X PBS+ 10% HS) to prevent unspecific binding. 
Primary antibodies were diluted in blocking solution and cells were incubated with 
primary antibody according to antibody data sheet.  After three times washing step with 
PBS, fluorescently labelled secondary antibodies diluted in blocking buffer were applied 
for 30 min and cells were washed again with PBS for three times. For nuclei staining, 
4’6- diamidino-2-phenylindole (DAPI) was used for 2 min followed by two additional 
washing steps. Finally, coverslips were briefly submerged in ddH2O for the removal of 
residual buffer salts and mounted in moviol on object slides. 
3.6. Proteomics 
3.6.1. Mass Spectrometry (MS) based analysis 
The IPed samples as described previously was subjected to Mass spectrometry-based 
analysis with the Proteomics core facility from IMB, Mainz. 30µl of sample/IP was 
needed for labelling peptides with Dimethyl (DML method) and after running both 
forward and reverse experiment, the output was analyzed by MaxQuant Software 
including removal of potential common contaminants and reverse database entries. 
Only identified proteins with at least two peptides were allowed. The threshold was set 
to a default value of 2x enriched on a log2 scale.  
 
3.6.2. Pulsed-SILAC (pSILAC) protocol 
SILAC is an invaluable tool for studying protein synthesis and turnover in response to 
stimuli. Furthermore, protein abundance can be monitored in a temporal fashion with 
the SILAC method by using a different isotopic version of an amino acid for each time 
point whereas pSILAC (pulsed SILAC) can quantitate the relative levels of newly 
synthesized proteins in one experiment and for two conditions in a given time as well as 
the relative levels of remaining preexisting proteins by means of a three-channel 
labelling.  
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In this experiment, SILAC-DMEM medium along with three different isotopic version of 
Lysine and Arginine and dialyzed FBS were purchased from IMB, Proteomics core 
facility.  
First, SILAC-Light medium was prepared (DMEM, Lys-0, Arg-0, 10% dialyzed FBS) and 
cells were plated and cultured in Light medium until they reach 70% confluency. For Oli-
neu cells, Modified SATO-SILAC medium was used in each case (See recipe). The next 
day after plating, cells were transfected with control or NG2 ICD-construct by FuGENE 
reagent and cells were incubated in Light medium. After 16-18 hours post-transfection, 
SILAC Light medium was discarded, cells were washed with pre-warmed PBS for three 
times. Transfected cells were replaced with ‘SILAC-Medium-heavy’ medium (DMEM, 
Lys-4, Arg-6, 10% dialyzed FBS) in one condition (e.g. for control) and ‘SILAC-heavy’ 
medium (DMEM, Lys-8, Arg-10, 10% dialyzed FBS) in another condition (e.g. for ICD). 
Parallelly, in a same but separate experiment, transfected cells were reverse-labelled 
(e.g; control with ‘Heavy’ and ICD-TF with ‘Medium-heavy’). After 18-20 hours post-
incubation, mediums were discarded, cells were washed and trypsinized with TE-Low 
and pelleted down (800 rpm, 10 mins). Cells were resuspended in PBS and counted 
with a hemocytometer. Equal number of cells were taken from each experimental 
condition and mixed in a 1:1 ratio. Cells were immediately lysed with lysis buffer (PBS, 
1% TX-100, 1X PI) on ice and protein concentration was measured by BCA method. 
Desired amount of lysate from forward and reverse-labelled conditions were sent to IMB 
proteomics core facility, Mainz for quantitative MS analysis.  
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Fig 3.3. Mechanistic principle of conventional SILAC and pulsed SILAC (Taken from Zissimos 
Mourelatos, Nature, 2008) 
 
Statistical analysis 
Each experiment was repeated independently at least three or more times. The 
numerical data of multiple experiments is expressed as mean ± standard error of the 
mean (SEM). Statistical analysis was done using Excel and Graph Pad Prism. For 
significance analysis, normal distribution was tested by the Shapiro-Wilk Normality test. 
For parametric distributed datasets two tailed t-test was applied: In the case of non-
parametric distribution, Mann-Whitney or Wilcoxon Signed rank test was used. 
Significance was classified as follows: *, p≤0.05; **, p<0.01; ***, p<0.001; n.s. p>0.05.  
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4.Results 
In this thesis, the cellular localization of the NG2 ICD after cleavage of NG2 was 
addressed. This also includes the role of the predicted NLS sequences. Furthermore, as 
most of the ICDs liberated by RIP is involved in regulating gene expression, cell 
signaling pathways and cellular processes, function of NG2 ICD released after cleavage 
was addressed.  
4.1.1. Generation and functional analysis of NG2 expression constructs 
To address the localization and function of released NG2 ICD, different NG2 expression 
constructs were derived from pRK5 constructs used in the study by Sakry et al., in 
2015, by PCR amplification and sub-cloned into a Flag-tagged vector backbone (p3X-
Flag CMV14 expression vector, c-terminally tagged (Fig 4.1). NG2 DEL expresses a 
short recombinant version of full-length NG2 (consisting the signal sequence, one-fourth 
of the extracellular portion including two laminin G-type motifs, a transmembrane 
domain, and intracellular region).  
 
 
 
 
 
 
 
 
 
 
 
Fig 4.1. General workflow for functional analysis of NG2 expression constructs 
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Two other constructs, expressing only the intracellular domain (NG2 ICD, AA 2251-
2327 (UniProt: Q8VHY0) and without the predicted Nuclear Localization Signal (NLS) of 
ICD (NG2 ICDΔNLS, AA 2259-2327) were generated as well.  
For studying the expression of the generated flag-tagged constructs, OPC were 
transfected, and 48 hours post-transfection, lysates were prepared and analyzed by 
western blot (WB) analysis. Fig.4.2. shows that NG2 DEL generates two distinguishable 
fragments, one at 65 kD indicating the full-length (FL) protein and another at 14 kD 
corresponding to the membrane-bound CTF. NG2-ICD runs at ~10 kD and owing to the 
deletion of predicted NLS motif (2251-2259 bases of ICD sequence), NG2 ICDΔNLS 
runs (~9 kD) just below ICD. In this experiment, Na-butyrate was used to enhance the 
protein expression in vitro as ICDΔNLS, being small-sized and truncated construct, was 
unstable and hard to detect in WB with NG2-cyto specific antibody. The expression of 
the flag epitope was also checked by probing the membrane with an anti-flag antibody. 
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Fig.4.2. Diagram of used NG2 expression constructs and their expression. 4.2. (A) Schematic 
representation of NG2 protein undergoing Regulated Intramembrane Proteolysis (RIP) by the sequential 
action of α and ϒ-secretases. 4.2. (B, C) Schematic representation of the NG2 DEL, NG2 ICD and 
ICDΔNLS expression constructs used in this study. All NG2 expression constructs were tagged with 3X-
Flag (C-terminal). 4.2. (D) Western blot analysis of post-nuclear (PN) cell-lysates of the OPC cell-line, Oli-
neu transfected with various NG2 expression constructs. Flag-tagged constructs revealed their size-
based differences, NG2 ICD runs at 11 kD, and NG2 ICDΔNLS (NLS was deleted) runs just below ICD at 
10 kD. NG2 DEL (65kD) strongly shows processed membrane-bound CTF (15 kD) at the shown lower 
molecular masses. Na-butyrate was used only in this experiment to enhance the expression of ICD 
constructs. (Taken from Nayak T. et al., 2018) 
4.1.2. Nuclear localization of NG2 ICD was detected by subcellular fractionation 
assay  
To analyze the localization of cleaved NG2 ICD, subcellular fractionation assay was 
performed with Oli-neu cells overexpressing flag-tagged NG2 expression constructs. 
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The separated cytoplasmic and nuclear lysates were analyzed by western blot (WB) 
and probing the membrane with anti-flag antibody revealed the presence of NG2 ICD in 
both cytosolic and nuclear fraction with a higher level of ICD in the cytosol. NG2 
ICDΔNLS was used as an additional control here to check the function of the predicted 
NLS motifs. In contrast to NG2 ICD, ICDΔNLS expression was only detected in the 
cytosolic but not in the nuclear fraction indicating the function of the NLS motifs in 
directing ICD to the nucleus. (Fig 4.3.) Lamin B and tubulin was used as a nuclear and 
cytosolic marker respectively, and the very low detection level of Lamin B in cytosolic 
fraction and undetected tubulin in nuclear fraction indicates about the purity of the 
performed fractionation.  
               
 
 
 
 
 
 
Fig.4.3. Sub-cellular fractionation assay. Fractionation assay was done from Oli-neu after 
overexpressing ICD or ICDΔNLS for 48 hours. Lamin B and α-tubulin were used as nuclear and cytosolic 
markers respectively. NG2 ICD was found in nuclear fraction whereas NG2 ICDΔNLS expression was 
limited to cytosolic fraction only. (Taken from Nayak T et al., 2018) 
 
4.1.3 High-resolution Imaging confirmed the nuclear presence of cleaved NG2 ICD 
in cultured OPC 
To confirm the specificity of the fractionation assay result, as a next approach, high-
resolution confocal microscopy was used. NG2 ICD-flag or ICDΔNLS-flag 
overexpressing Oli-neu cells were immunostained with anti-flag antibody (in red). 
H2B(green) was used as a nuclear marker, and DAPI (blue) was used to stain nuclei. 
Flag staining was detected as a homogeneous pattern over the cell including nuclei in 
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case of ICD, whereas ICDΔNLS revealed extranuclear staining excluding nuclei. (Fig 
4.4. A). For further validation, z-stack images of transfected cells were taken and 
analyzed by ImageJ, 3D viewer plugin where cells were represented as an orthogonal 
section and both the XY and YZ format of ICD-transfectants detected the presence of 
flag staining (red) inside the nucleus. In contrast to that, ICDΔNLS showed no staining 
inside the nucleus. Tubulin (green) was used as a nuclear envelope marker. (Fig 4.4.B). 
Supporting the subcellular fractionation assay result, immunostaining also revealed that 
the expression of cleaved ICD was much higher in the cytosol than nucleus although 
ICD was detected in a low level in nucleus too in Oli-neu cells.  
In a separate experiment, to assess whether nuclear import of cleaved NG2 ICD is an 
active process, Oli-neu cells were transfected only with ICD-flag constructs and treated 
with Ivermectin (Sigma). Ivermectin is a potent inhibitor of Impα/β1-dependent nuclear 
transport, and thus cells accumulate classical NLS-dependent active import of proteins 
when treated with Ivermectin. However, Ivermectin is cytotoxic and was used in this 
experiment at a very low concentration of 10 µM after 24 hours of transfection. 
Ivermectin was added in the culture medium just 2-4 hours before fixing the cells. From 
Fig 4.4.C, it was evident that ICD expression was restricted in the peri-nuclear region 
only when treated with Ivermectin while Ivermectin-untreated ICD-expression was 
detected again in a homogeneous pattern including nuclei.   
Altogether, these experiments support in favor of NLS-dependent active transport of 
cleaved NG2 ICD to the nucleus at a low level compared to its cytosolic expression.  
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Fig.4.4. High-resolution imaging of NG2 expression constructs overexpressing Oli-neu cells. (A). 
Confocal laser scanning microscope images (z-stack, max. intensity projection) of Oli-neu expressing 
NG2 ICD or ICDΔNLS (flag; red). Cells were immunostained with anti-flag antibody. NG2 ICD shows a 
distinguishable homogeneous staining pattern including nucleus where in case of ICDΔNLS, expression 
remained cytosolic. H2B (green) and DAPI (blue) were used as nuclear markers. (B) Three-dimensional 
orthogonal view of a z-stack image of an Oli-neu cell showed the presence of NG2 ICD (red) within the 
nucleus, whereas ICDΔNLS expression was limited to the cytosol and peri-nuclear area. Lamin B (green) 
was used as a nuclear envelope marker. (Scale bar= 10 µm). (C) Oli-neu cells overexpressing ICD were 
treated with a nuclear import inhibitor, Ivermectin. Treatment with Ivermectin limited nuclear expression of 
ICD as shown in the confocal images (Scale bar= 10 µm). (Taken and modified from Nayak T. et al., 
2018) 
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4.2. Characterization of ICD-interactome 
4.2.1 Investigation of ICD-interactome by IP-MS study 
To elucidate the function of NG2 ICD, it was important to characterize its interactome. 
HEK293 cells were transfected with ICD-Flag or BAP-Flag (control) constructs and 48 
hours post-transfection, cell lysate was prepared, and immunoprecipitated with pre-
conjugated, magnetic anti-flag antibody beads. HEK cells were chosen to perform 
immunoprecipitation (IP) due to higher transfection efficiency. A schematic 
representation of the designed IP-MS experiment is given below. The IPed samples 
were subjected to Mass Spectrometry (MS) based analysis which was performed by 
IMB proteomics core facility, Mainz. Three independent experimental replicates were 
sent for MS analysis.  
 
 
 
 
 
 
 
 
 
 
 
Fig.4.5. Schematic representation of IP-MS workflow. 
 
The samples were analyzed by MaxQuant Software (www.Maxquant.org). The 
database, used for analysis, was restricted to peptides and the corresponding proteins 
derived from human species and served as the basis for the actual selection of potential 
candidates. As a first filtering method, only identified proteins with at least two peptides 
SDS-PAGE followed by tryptic digestion 
HEK cells transfected with ICD-flag or BAP-flag(control) 
ICD-flag 
Mixed 1:1 
After 48 hours 
BAP-flag 
Immunoprecipitation with magnetic anti-Flag antibody-conjugated beads 
Beads were washed three times and immunocomplex was eluted by heating 
the beads.  
Peptide labelling by DML and MS analysis 
 
After 2-4 hours 
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were allowed. The second filtering contains an overview of identified protein groups 
present in forward and reverse experiment with at least one detected ratio.  
The threshold was set to a default value of 2x enriched. The common contaminations, 
appearing regularly in MS analyses including keratins and IgG proteins were discarded 
from the provided lists of identified proteins. 
 
4.2.2 Gene Ontology-based analysis of ICD-interactome.  
Table 16 summarizes the top 25 candidates detected to be enriched in NG2-ICD_IP 
samples, passing the threshold of the selection criteria mentioned above and these 
candidates appeared at least twice in the three independent IP-MS analysis.  Among 
the topmost candidates, several translation factors including ribosomal subunits were 
highly upregulated. The output also indicates precipitated proteins that are actively 
associated with DNA unwinding (XRCC5, XRCC6) and DNA replication process 
(MCM7, MCM3) and proteins that regulate the transcription machinery (CNBP, GTF II-I, 
PHF5A).  
Table 16. List of top 25 putative interaction partners of cleaved NG2 ICD found by IP-MS 
study.  
 
Gene ID Protein Name Average Fold-change 
(ICD/CNT) 
Average 
Sequence 
Coverage (%) 
EEF2 Elongation factor 2 5.88 57.5 
HSPA1A Heat shock 70 kDa protein 1A 5.35 58.5 
PCMT1 Protein-L-isoaspartate O-
methyltransferase 
4.49 31.75 
PRPS1 Ribose-phosphate pyrophosphokinase 1 3.6 34.15 
EIF4B Eukaryotic translation initiation factor 
4B 
3.58 20.1 
KLHL9 Kelch-like protein 9 3.44 28.3 
ERP44 Endoplasmic reticulum resident protein 
44 
3.36 22.56 
EIF4A1 Eukaryotic initiation factor 4A-I 3.23 38.75 
EEF1G Elongation factor 1-gamma 3.2 32.85 
XRCC6 X-ray repair cross-complementing 3.16 13.15 
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Table 16. Summarization of top 25 putative interaction partners of cleaved NG2 ICD identified by IP-MS. 
The candidates passed the threshold criteria set by MaxQuant analysis and were altered in the same 
ratio in both forward and reverse peptide labeling. The candidates were found in at least two independent 
IP-MS analysis performed in NG2 ICD-overexpressing HEK cells.  
  
Table 17. List of enriched functional clusters of ICD-interactome by DAVID  
protein 6 
XRCC5 X-ray repair cross-complementing 
protein 5 
3.12 10.8 
TCP1 T-complex protein 1 subunit alpha 3.04 25.25 
PRDX1 Peroxiredoxin-1 2.95 53.5 
MCM7 DNA replication licensing factor MCM7 2.95 11.55 
GNB2L1 Guanine nucleotide-binding protein 
subunit beta-2-like 1 
2.82 31.1 
SERPINH1 Serpin H1 2.42 17.4 
PCBP2 Poly(rC)-binding protein 2 2.41 23.15 
MCM3 DNA replication licensing factor MCM3 2.2 12.5 
RPS28 40S ribosomal protein S28 2.19 36.6 
RPS12 40S ribosomal protein S12 1.96 30.7 
CNBP Cellular nucleic acid-binding protein 1.94 36.75 
PHF5A PHD finger-like domain-containing 
protein 5A 
1.51 33.65 
EIF3 Eukaryotic translation initiation factor 3  1.46 14.35 
GTF2I General transcription factor II-I 0.83 14.3 
EWSR1 RNA-binding protein EWS 0.73 11.8 
Annotation 
Cluster 1 
 Enrichment 
Score: 3.3278 
    
      
Category Term Count % P-
Value 
Genes 
Biological 
Process 
cell-cell 
adhesion 
5 21.73 3.85E-
4 
EEF1G, PCMT1, EEF2, HSPA1A, 
PRDX1 
Molecular 
Function 
poly(A) RNA 
binding 
14 60.86 1.41E-
10 
XRCC5, CNBP, TCP1, XRCC6, 
EEF2, PRDX1, SERPINH1, EIF4B,  
     
RPS28, PCBP2, EIF4A1, RPS12, 
PHF5A, EWSR1 
Annotation 
Cluster 2 
Enrichment 
Score: 2.58 
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Table 17. summarizes the overrepresented annotation clusters revealed by gene-ontology analysis of 
ICD-IP interactome by DAVID (NIH2.0). Every cluster is composed of two categories: altered biological 
process and molecular function. The genes associated with each cluster is also mentioned in the table.  
 
 
Fig.4.6. Pathway analysis of the candidates by Enrichr database reveals the following over-
regulated pathways in NG2 ICD-IP samples.  
 
 
 
 
 
 
 
 
Biological 
Process 
DNA duplex 
unwinding 
3 13.04 0.0014 XRCC5, XRCC6, MCM3 
Molecular 
Function 
DNA binding 7 30.43 0.0174 XRCC5, CNBP, MCM7, GTF2I, 
XRCC6, PHF5A, MCM3 
Annotation 
Cluster 3 
Enrichment 
Score: 1.804 
    
Biological 
Process 
translational 
initiation 
4 17.39 0.000/ EIF4B, RPS28, EIF4A1, RPS12 
Molecular 
Function 
cadherin binding 
involved in cell-
cell adhesion 
5 21.73 4.88E-
4 
EEF1G, PCMT1, EEF2, HSPA1A, 
PRDX1 
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4.2.3 NG2 ICD co-precipitates with translation factors 
In another experimental approach, the immunoprecipitated samples (ICD and BAP-flag 
IP) were run on a gradient gel, and the gel was stained by Coomassie Blue. After 
staining, the unique observed bands at 100 kD and 70 kD (indicated by the arrow in Fig 
4.7.A) from ICD_IP lane was excised by a clean razor and sent for Mass-spectrometry 
based band-identification analysis. MS revealed that the two unique precipitated bands 
in ICD_IP lane were eEF2 (Elongation factor 2; 95 kD) and eIF4B (Initiation factor 4B; 
70 kD) further confirming the data revealed in the whole IP sample analysis by MS.  
To confirm that eEF2 and eIF4B co-associates with NG2 ICD, Co-IP was performed 
with IPed samples (HEK cells and flag pull down as previously mentioned) which were 
run on a gel and after transferring the separated proteins on a PVDF membrane, it was 
probed with anti-eEF2 and anti-eIF4B antibody. CoIP showed the co-precipitation of the 
translation factors (eEF2 and eIF4B) along with NG2 ICD showing the specificity of MS 
data. Cofilin was used as a negative control in the experiment to rule out the possibility 
of random pull-down of any high-abundant cytosolic proteins. Bacterial alkaline 
phosphatase (BAP) is a 51 kD protein and thus indistinguishable from the heavy 
antibody chain (55 kD) shown in the western blot (WB). The CoIP experiment was 
reproducibly repeated three times independently.  
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Fig.4.7. Validation of IP-MS targets by Co-Immunoprecipitation. (A) Representative Coomassie-
stained gradient gel of NG2 ICD (ICD IP) and BAP-overexpressing samples (Control IP) after IP from 
HEK cells. Unique bands present in ICD-IP lane are indicated by black arrows, and red arrows indicate 
heavy and light chain (55 kD and 25 kD respectively) from anti-flag IgG used for IP. The unique bands 
were excised from gel between 70 and 100 kD and subjected to MS-based analysis. (B) Representative 
CoIP blot for validation of ICD_IP candidates (Eef2 and Eif4B) found by IP-MS screening and band-
identification analysis. 10% input was loaded. Cofilin was used as negative control to check that ICD is 
not randomly pulling down highly abundant cytosolic control.  
 
4.3. Translational regulation 
 4.3.1 NG2 ICD regulates translational rate in cultured cells 
Translation was one of the highly regulated biological processes (based on Gene 
Ontology of NG2-ICD interactome, Fig 4.6) and co-precipitation of translation factors 
along with NG2 ICD was also shown. Next, it was addressed if the NG2 ICD exerts 
major influences on translation.  
To address this, the SuNSET-WB technique was chosen. SuNSET assay was first 
described in the work of EK Schmidt et al., 2009 and termed as Surface Sensing of 
translation (SuNSET) where changes in global protein synthesis rate can be quantified 
4.7.B 4.7.A 
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in a heterogeneous cell population in vitro (2009) and in vivo (Goodman et al., 2013). 
The technique relies on the incorporation of puromycin, which is a structural analogue of 
aminoacyl-transfer RNA (aminoacyl-tRNA; specifically, tyrosyl-tRNA) and thus when 
used in low concentration can be incorporated into elongating polypeptide chain by 
forming a peptide bond. (Fig 4.8) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.8. Working principle for SUnSET techniques. (Taken from CA Goodman et al., 2013) 
 
Higher puromycin incorporation thus indicates a higher translation rate, which can be 
quantified using an anti-puromycin antibody.  
Following this principle, HEK293 and Oli-neu cells, overexpressing ICD or control, were 
incubated with puromycin in the culture medium and lysed afterward for WB as 
described above. Anisomycin, a translation blocker, was used as a negative control to 
show that puromycin incorporation takes place only in active ongoing nascent 
polypeptide chains.  
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In addition to cell-lines, SuNSET assay was also performed with primary OPC (pOPC), 
obtained from the total brains of the Postnatal day (P) P6-9 of C57Bl/6N mice by 
magnetic isolation (MACS). At DIV1, pOPC were transfected with siCNT and siNG2, 
and after 24 hours of siRNA transfection, cells were incubated with puromycin as 
described above and subjected to WB analysis to determine active translation rate.  
Since mTORC1 is the central regulator of translation, another experiment was deigned 
to investigate the specific involvement of mTORC1 on translation. Oli-neu cells, 
overexpressing control or ICD, were incubated with Temsirolimus (TM), a mTORC1 
inhibitor, followed by puromycin treatment and were subjected to WB analysis.  
ICD-transfectants showed increased puromycin incorporation by ~90% in HEK and 
~70% in Oli-neu cells compared to controls, reflecting higher translation rate (Fig. 
4.9.B). To validate that the observed increased translation rate is specific for cleaved 
NG2 ICD, NG2 DEL was used as an additional control.NG2 DEL mimics membrane-
bound NG2 and undergoes cellular RIP yielding small amounts of ICD. NG2 DEL 
expression in Oli-neu resulted in a smaller increase in the puromycin signal compared 
to control (approximately 22%) which is likely to be mediated by endogenously cleaved 
NG2 ICD. Strikingly, treatment with temsirolimus (TM) abolished the NG2 ICD-driven 
upregulation in translation in Oli-neu (ICD + TM) compared to the control (TM) (Fig 4.9). 
Knock-down of endogenous NG2 (siNG2) in primary OPC by siRNA resulted in 40 % 
reduced NG2 levels, and total translation rate was also downregulated by ~30 % in 
pOPC transfected with siNG2 compared to control in accordance with the previous 
observation (Fig. 4.9).     
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Fig.4.9. NG2 ICD upregulates translation rate. (A) HEK (n=5) and Oli-neu (n=4) cells were treated with 
10µM puromycin after 48 hours of transient transfection with different NG2 expression constructs (DEL 
and ICD) or empty expression vector (control). Western blot analysis of PN cell-lysates after puromycin 
treatment was done with a specific antibody against puromycin, the translation blocker Anisomycin was 
used as a negative control. Additionally, a selective mTORC1 complex inhibitor, Temsirolimus (TM), was 
used (10µM) to investigate mTORC1 specific contribution to total translation rate between control (+TM) 
and ICD (+TM) (n=3). (B) Densitometric analysis was done for puromycin (from 15 kD to 250 kD) 
normalized to GAPDH. NG2 ICD showed an increase of puromycin incorporation (translation rate) by 
70% in Oli-neu and by 90% in HEK cells compared to control. When treated with a mTORC1 inhibitor 
(TM), the ICD-mediated effect on translational is reduced slightly below control levels (control+TM vs. 
ICD+TM), indicating a mTORC1-dependent increase and a mTORC1-independent decrease of 
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translation by NG2 ICD overexpression. NG2 DEL mimics full-length NG2, and it predominantly 
expresses membrane-bound NG2 CTF but not cleaved ICD (Fig.1B&2A). NG2 DEL was used as an 
additional control to confer cleaved ICD-specificity in stimulating translation, and it shows only ~22% 
increase in translation rate compared to control (n=4). (C) Full-length NG2 knockdown (siRNA 
transfection) was performed in cultured primary OPC (pOPC) to check the effect on translation. (D) NG2 
knockdown (siNG2) in pOPC revealed a knockdown efficiency of around 40% compared to control 
(siCNT), translation (puromycin level) was reduced by ~30% by NG2 knock-down. (Data represents mean 
±SEM. Statistical analysis was done by two-tailed paired t-test after checking the data is normally 
distributed by the Shapiro-Wilk normality test by PRISM (GraphPad)). (Taken and modified from Nayak T. 
et al., 2018) 
 
4.3.2. NG2 ICD increases translation by modulating mTOR signaling components 
After establishing ICD-mediated translational effects in HEK, Oli-neu, and pOPC, the 
molecular mechanism causing this effect was investigated. Gene ontology-based 
Pathway analysis (of ICD interactome) by DAVID already suggested involvement of 
mTOR signaling cascade in this regard and previous SUnSET experiments with 
mTORC1 specific inhibitor implied the possibility of mTOR-cascade involvement in ICD-
mediated translational upregulation.  
The mammalian target of rapamycin (mTOR) signaling pathway co-ordinates both 
intracellular and extracellular signals and plays a significant role in regulating 
translation, cell metabolism, growth, proliferation, and survival. mTOR is the principal 
component of two structurally and functionally separate enzyme complexes, mTORC1 
and mTORC2, each having distinct downstream effectors. mTORC1 regulates 
translation by acting as a kinase for the downstream components involved in translation 
machinery, for example, 4E-BP1 and p70S6K1 whereas AKT, Serum and 
Glucocorticoid Kinase (SGK) and Protein-Kinase C (PKC) are downstream of 
mTORC2 (Jacinto et al., 2004, Ben-Sahra et al., 2017) and associated with cell survival 
and cellular metabolism (Sarbassov et al., 2005).  The diagram given below represents 
a simple flow-chart of mTOR and the associated signaling components.  
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Fig 4.10. Overview of the mTORC1 signaling cascade in translation regulation (Taken from 
Nobuyuki Takei et al., 2014) 
Given the context of ICD-mediated translational effect, the activity of mTORC1 was 
investigated. mTORC1 undergoes autophosphorylation at Ser2481 residue, and this 
phosphorylation stimulates its intrinsic catalytic activity. Phosphorylation at ser2481 is 
also increased upon mTORC1-activating stimulation (Soliman et al., 2010). In this 
study, the effect of cleaved ICD on p-mTORC1(Ser2481) was addressed. After 
transfection of ICD in both HEK and OPC, cells were lysed and subjected to immunoblot 
analysis. WB analysis revealed that ICD overexpression causes an upregulation of 
phosphorylated residue on an average of ~2.5 fold in both HEK and OPC. (Fig 4.11) 
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The ribosomal protein S6 kinase (S6K), a serine/threonine kinase that belongs to the 
AGC kinase family, is a well-established downstream target of mTORC1 and often used 
as a parameter to read out mTORC1 activity. mTOR kinase phosphorylates S6K1 at 
T389 which is the hydrophobic motif (HM) phosphorylation site (Pullen et al., Science, 
1998, Ali et al., 2005). Usually, S6K1 is associated with eIF3 (Translation initiation 
factor 3) and prevents its binding to mRNAs. Phosphorylation of S6K1 at T389 
causes dissociation from eIF3, and it then phosphorylates downstream components 
eIF4B and S6. Phosphorylation of eIF4B by S6K1 at S422 triggers its association with 
eIF3. (Holz et al., 2005, Shahbazian et al., 2006) and promotes translation initiation.  
Following this already established signaling paradigm, phosphorylated levels of 
S6K1(Thr 389) and eIF4B (Ser 422) was investigated in ICD-overexpressing conditions. 
WB analysis revealed that ICD overexpression causes an increase of ~50% in both p-
S6K1 (Thr389) and p-eIF4B (Ser 422) in HEK and OPC. (Fig 4.11) 
In addition, Oli-neu cells were transfected with siRNA (siCNT/siNG2) to obtain 
endogenous NG2 knockdown and its effect on the mTOR cascade. siNG2-treated Oli-
neu cells showed ~25-30% reduced mTOR and S6K1 phosphorylation in accordance 
with the previous observation. (Fig 4.12)  
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Figure 4.11. NG2 ICD overexpression increases phosphorylation of mTORC1 signaling 
components (A, C) Western blot analysis of post-nuclear (PN) lysate from NG2 ICD transfected HEK 
(n=3) and Oli-neu (n=4) cells compared to empty vector (control). (B, C, D) Quantification of western blot 
analysis. Phospho-specific expression of S6K1 (Thr389) is significantly upregulated in both cell lines and 
correlates with the increase of phospho-mTOR (Ser2481) levels. The downstream target of pS6K1, p-
eIF4B was also increased in both cell lines. (Data represents mean ±SEM. Statistical analysis was done 
by two-tailed paired t-test after checking the data is normally distributed by the Shapiro-Wilk normality test 
by PRISM (GraphPad). (Taken from Nayak T et al., 2018) 
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Figure 4.12. NG2 knockdown causes decreased phosphorylation of mTORC1 signaling 
components (A) WB analysis of mTOR cascade in NG2-knocked-down Oli-neu cells. (B)  In the NG2-
knockdown experiment, p-mTOR and p-S6K1 both were reduced (~20-25%) in NG2 knocked-down 
(efficacy 80%) Oli-neu samples compared to control. (Data represents mean ±SEM. Statistical analysis 
was done by two-tailed paired t-test after checking the data is normally distributed by the Shapiro-Wilk 
normality test by PRISM (GraphPad) (Taken from Nayak T et al., 2018) 
4.3.3. NG2 ICD modulates eef2/FMRP signaling pathway 
Among the various targets of S6K1, eEF2K (elongation factor 2 kinase) regulates 
translation elongation. eEF2K is a kinase which inactivates by phosphorylation (at Thr 
56 residue) its only known substrate, eEF2, causing a repressed translation elongation 
(Wang et al., 2001, 2014). Additionally, in the nervous system, S6K1 has been reported 
to phosphorylate the protein FMRP, which acts as a general repressor of translation 
(Narayanan et al., 2008). Mutation of FMRP is the causal link for the intellectual 
disorder; Fragile-X Mental Syndrome (Okray et al., 2015, Zalfa et al., 2003). FMRP is an 
RNA binding protein and has a wide range of substrates including dendritic mRNAs 
(Bassell et al., 2008) and thus play a key role in maintaining local translation and 
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neuronal development (Brown et al., 2001). In recent studies, eEF2 mRNA is 
recognized as another substrate of FMRP (Bagni et al., 2014, Richter et al., 2015) and 
FMRP/eEF2 signaling has been suggested to regulate dynamic translation of mRNAs 
involved in LTD in neurons (Park et al., 2008).  Furthermore, FMRP-KO mice show 
exaggerated protein synthesis (Darnell et al., 2011) due to hyperactive S6K1 signaling 
(Bhattacharjee et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.13.  Role of FMRP/eEF2K/eEF2 pathway in mGluR-LTD regulation (Taken from Park et al., 
2008) 
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Since the MS analysis of the ICD-interactome and independent band-identification 
analysis followed by CoIP validation confirmed the co-association of eEF2 with NG2 
ICD, the effect of the ICD on eEF2 was investigated. As FMRP is one of the most 
important candidates influencing neuronal development, synaptic strength and neuronal 
translation regulation and a strong association between FMRP and eEF2 is shown, the 
total cellular level of FMRP in ICD-overexpressing cells was additionally checked.  
WB analysis in an analogous manner as described above revealed a significant 
increase of total cellular levels of eEF2 (~50%) in ICD-transfectants (Fig 4.14.A) 
compared to control in both cell-types.  Additionally, the level of eEF2 mRNA level was 
checked, and surprisingly it was ~30% less in ICD than control suggesting the 
occurrence of possible post-transcriptional regulation at this level (Fig 4.14.C). This 
result was particularly intriguing as several recent studies reported that FMRP binds 
eEF2 mRNA and post-transcriptionally repress its translation ((Darnell et al., 2013, 
Brown et al., 2001). Strikingly, WB analysis showed significant downregulation of FMRP 
(~70%) in ICD-overexpressing Oli-neu cells. Downregulation of FMRP was lower in 
HEK compared to OPC, as FMRP is predominantly a neuronal and developmentally 
regulated protein and the ICD-mediated FMRP downregulation is very likely to be cell 
type and developmental stage-specific. (Fig 4.14.A, B).  FMRP protein is also reported 
to bind and stabilizes its own mRNA along with other target mRNAs and perturbation of 
intracellular protein level of FMRP regulates its mRNA binding and stabilization 
properties (Didiot et al., 2008). Hence in following experiments Fmr1 total mRNA level 
was checked by qPCR analysis and the data revealed that Fmr1 mRNA level was also 
~35% reduced in ICD-overexpressing conditions compared to control (Fig 4.14.C). 
Several studies have reported that FMRP exerts stabilization effect on PSD95 and MBP 
(Giampetruzzi et al., 2013, Zalfa et al., 2007) mRNAs and hence an experiment was 
performed with a transcription blocker DRB (5,6 Dichlorobenzimidazole 1-β-D 
ribofuranoside) to study if ICD-mediated FMRP downregulation affects RNA stability of 
these above-mentioned mRNA candidates (Fig 4.14.D). Preliminary data revealed that 
both targets have reduced stability in ICD-overexpressing Oli-neu cells compared to 
control.   
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Figure 4.14. NG2 ICD regulates expression of eEF2 and FMRP 
(A) Western blot analysis of post-nuclear (PN) lysate from NG2 ICD transfected HEK (n=6) and Oli-neu 
(n=7) cells compared to empty vector (control). PN lysates were prepared 48 hours after transfection. (B) 
Total protein levels (normalized against GAPDH) of eEF2 were increased in both cell-lines, while FMRP 
protein levels were significantly reduced after ICD-overexpression only in Oli-neu. (C) qPCR analysis of 
eEF2 and Fmr1 mRNA showed that ICD-overexpression leads to 30% and 40% reduction respectively in 
Oli-neu samples. (D) Schematic representation of experimental design for studying ICD-mediated effect 
on stabilization of FMRP target mRNAs, taking DRB (5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside) 
as a transcription blocker. (E) qPCR analysis of DRB-treated ICD/CNT overexpressing Oli-neu cells 
revealed that ICD overexpression causes destabilization of two FMRP targets; PSD95 and MBP. (Data 
represents mean ±SEM. Statistical analysis was done by two-tailed paired t-test after checking the data is 
normally distributed by the Shapiro-Wilk normality test by PRISM (GraphPad). (Taken from Nayak T et al., 
2018) 
 
Results 
 
78 | P a g e  
 
4.4. Characterization of ICD-mediated newly synthesized proteome 
4.4.1. De novo proteome profiling of ICD-overexpressing population by pSILAC  
After establishing the altered signaling cascade associated with NG2 ICD-driven 
translational upregulation, the characterization of newly synthesized proteome upon ICD 
overexpression was addressed.  
One of the emerging, cutting-edge tools for studying the de novo proteome after a given 
stimulation or transfection is pulsed SILAC (pSILAC). pSILAC is a modified form of 
conventional SILAC where proteins are labeled by incorporation of two different 
isotopes of the same amino acid over a 3-5 generation of cultured cells. In contrast, 
pulsed SILAC can distinguish the newly synthesized proteome from the pre-existing 
protein pool by using three-channel labelling over a brief period. The procedure 
described in the publication by Björn Schwanhäusser et al, 2009, Proteomics, was 
followed in this study with some modifications for this experiment (Fig 4.15) (for details, 
see M&M).  
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.15. Schematic representation of the pSILAC workflow. 
 
Medium-Heavy medium(M) 
Transfection 
Light Medium (L) 
Control ICD 
Control ICD 
Pulse-labeling 
Heavy medium(H) 
 15 hours 
24 hours 
Newly synthesized 
proteome 
Mixed 1:1 ratio 
MS analysis 
Results 
 
79 | P a g e  
 
 
MS analysis of pSILAC samples from Oli-neu cells successfully characterized newly 
synthesized protein after ICD-overexpression. Gene-ontology based functional analysis 
of the enriched candidates suggested that many of the upregulated proteins are 
associated with DNA replication and repair, mTOR signaling pathways and proliferation 
(Fig 4.16). List of top 20 candidates from pSILAC analysis with their gene ID, fold-
change and functions are summarized in the table below. (Table 18), These candidates 
were reproducibly found in both forward and reverse SILAC labelling.  
 
Table 18. Summarization of upregulated candidates obtained from pSILAC-MS analysis  
 
Gene ID  Protein name Fold Change 
(ICD/CNT) 
(log2 scale) 
Function  
Hsd17b8 Estradiol 17-beta-
dehydrogenase 8 
1.68 Estrogen metabolism, oxidation-reduction 
process 
Phldb1 Pleckstrin 
homology-like 
domain family B 
member 1 
1.17 Regulation of EMT transition, embryo 
morphogenesis 
Sdcbp Syntenin-1 1.39 Positive regulation of cell proliferation, 
migration, cell cycle, TGF-beta signalling 
pathway 
Adnp Activity-dependent 
neuroprotector 
homeobox protein 
1.1 transcription factor, neuronal development, 
regulation of p53 pathway 
Lig3 DNA ligase 3 0.88 DNA replication, base-excision repair, cell 
cycle 
Eefsec Selenocysteine-
specific elongation 
factor 
0.74 Translation elongation, protein 
biosynthesis.  
CDKn2aip CDKN2A-
interacting protein 
0.71 p53 binding, regulation of cell growth 
and DNA damage.  
Cox7a2l Cytochrome c 
oxidase subunit 7A-
related protein 
0.64 regulation of oxidative phosphorylation 
Exoc4 Exocyst complex 
component 4 
0.64 vesicle exocytosis, synaptic transmission, 
oligodendrocyte differentiation 
Lsm2 U6 snRNA-
associated Sm-like 
0.61 mRNA splicing 
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Table 18 summarizes the top 20 upregulated candidates in ICD over-expressing cells obtained by 
pSILAC-MS analysis with their gene ID, fold-change and functions. Many of the upregulated proteins are 
associated with DNA replication, cell growth, cell differentiation, and p53 binding while the downregulated 
candidates are mostly involved in ubiquitination and protein transport.   
 
 
 
 
 
 
 
 
protein 
Mon2 Protein MON2 
homolog 
0.6 protein transport 
Rqcd1 Cell differentiation 
protein RCD1 
homolog 
0.55 Transcription and translational regulation, 
cell differentiation 
Rae1 mRNA export 
factor 
0.52 Cell division, mitotic spindle formation, 
nucleocytoplasmic transport 
Wdr18 WD repeat-
containing protein 
18 
0.51 cellular development, migration 
Ethe1 Persulfide 
dioxygenase 
ETHE1 
0.49 suppress p53-induced apoptosis, 
metabolic activity 
Get4 Golgi to ER traffic 
protein 4 homolog 
0.48 maintenance of unfolded protein by ERAD 
pathway 
Fmnl Formin-like protein 0.42 cortical actin cytoskeletal organization, cell 
morphogenesis 
Fbxo22 F-box only protein 
22 
0.41 positive regulation of protein 
ubiquitination, myotube differentiation 
Smarcb1 SWI/SNF-related 
regulator of 
chromatin 
0.4 cell cycle and differentiation regulator, p53 
binding, DNA repair and chromatin 
remodeling 
Dnajb1 DnaJ homolog 
subfamily B 
member 1 
0.4 positive regulation of ATPase activity, 
chaperone co-factor 
Csk Tyrosine-protein 
kinase CSK 
0.4 Oligodendrocyte differentiation, brain 
development, postive regulation of MAPK 
pathway 
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Fig.4.16.  Gene-ontology based analysis of pSILAC-MS candidates. pSILAC-enriched putative 
upregulated proteins was analyzed by using FUNRICH analysis tool. Altered biological functional 
annotation based on gene ontology represented translation, DNA repair, and DNA replication to be 
significantly enriched.  
 
4.4.2 Activity-dependent neuroprotective protein (ADNP) expression was 
regulated by cleaved NG2 ICD 
For validating the pSILAC data, ADNP was chosen as one of the candidates as it was 
highly regulated both in forward and reverse SILAC experiments in an equal manner. 
Activity-dependent neuroprotector homeobox (ADNP) was initially identified in brain 
tissue with transcription factor activity (Zamostiano et al., 2001). ADNP has a high 
abundance in proliferative tissues, and inhibition of ADNP protein expression caused a 
significant reduction in metabolic activity in the target cells coupled with increases in the 
tumour suppressor p53 (Amson et al., 2000). In OPC, ICD-overexpressing cell 
population showed a significant increase of ADNP total protein expression (~40%) 
compared to control by WB analysis (Fig 4.17).  
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Fig.4.17. Validation of pSILAC-enriched candidate (A) RNA-Seq data for ADNP expression in different 
neuronal cells were obtained from www.brainrnaseq.org. ADNP is highly expressed in OPC, but its 
expression is downregulated as OPC matured into myelinating OLs. (B) ADNP protein expression was 
investigated in ICD-overexpressing Oli-neu cells, and the data revealed that ADNP was ~2-fold higher in 
ICD compared to control.  
 
4.5. NG2 ICD alters the cell-cycle kinetics 
4.5.1 NG2 ICD increases cell population in S-phase 
Since the GO-based proteomics result suggested an enrichment of DNA repair and 
replication pathway, as a next approach, the cell-cycle kinetics after ICD-overexpression 
was studied. To study cell-cycle distribution, HEK cells overexpressing NG2 ICD or 
BAP-flag (control) were fixed 24 hours after transfection and intracellularly 
immunostained with anti-Flag-FITC conjugated antibody (details in M&M). The cell cycle 
distribution revealed that in the ICD overexpressing cells, 45.95% ±6.53% of the cells 
were in S-phase compared to 35.41%± 6.7% in control population giving a significant 
10% S-phase shift mediated by ICD (Fig. 4.18).  
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Fig 4.18. NG2 ICD shifts S-phase population in HEK cells. (A) Representative images of DNA 
histogram analysis for cell-cycle distribution in asynchronized HEK cells transfected with ICD-flag (ICD) or 
BAP-flag (control). Propidium iodide (PI) was used for DNA staining. Only flag-FITC+ cells were analyzed 
for PI quantification. (B) Quantification of FACS data from HEK cells represented in a stacked bar column 
shows that ICD promotes the cell population in S-phase by ~10%. Experiments were done in three 
independent sets (n=3) where 2000 events counted for each condition in each experiment. (Taken and 
modified from Nayak T et al., 2018) 
 
FACS experiments were unsuccessful with Oli-neu cells owing to lower transfection 
efficiency compared to HEK cells. However, another experimental approach was taken 
to study S-phase effect in OPC. Oli-neu cells were immunostained for PCNA 
(Proliferating cell nuclear antigen) which is an S-phase specific marker as PCNA 
associates with active replisome (Mike O’Donnell and Huilin Li., 2016, Chagin et al., 
2016). PCNA-staining showed that in ICD-overexpressing conditions, 21.04%± 1.26%  
Oli-neu cells were PCNA+ (out of total counted DAPI+ cells) whereas in the control  
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Figure 4.19.  NG2 ICD overexpression increases PCNA+ cell numbers in Oli-neu cells (A) Oli-neu 
cells are immunostained with the S-phase marker, anti-PCNA antibody (red) and indicate increased 
PCNA-associated nuclear puncta when transfected with ICD (stained with anti-Flag antibody, green). Cell 
nuclei were stained with DAPI (blue). (C) Quantification of PCNA staining in Oli-neu reveals that the 
proportion of PCNA+ cells out of total cells (total counted DAPI+) is significantly increased in case of ICD 
overexpression (21.04%± 1.26%) compared to control (9.33± 2.03%), a total of ~250 cells were counted 
for quantification. (B, C) WB analysis of G1 to S-phase progression regulator, Cyclin E, revealed that 
Cyclin E was increased ~2 fold in ICD compared to control. (Data represents mean ±SEM. Statistical 
analysis was done by two-tailed paired t-test after checking the data is normally distributed by the 
Shapiro-Wilk normality test by PRISM (GraphPad). (Taken from Nayak T et al., 2018) 
 
population 9.33%± 2.01% Oli-neu cells were PCNA+ (out of total DAPI+ cells) (Fig. 
4.19). PCNA-staining quantification also revealed a significant 10% increase of Oli-neu 
cells in accordance with the previous observation found by FACS analysis in HEK cells.  
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Cyclin E is one of the principal regulators of G1 to S-phase progression in cell-cycle 
kinetics. Cyclin E expression is increased during the G1 phase and reaches its peak as 
cells enter into S-phase (Yang et al., 2012,). To address the ICD-mediated observed the 
S-phase effect on a molecular level, Cyclin E total cellular expression was checked by 
WB in ICD overexpression and control condition. The protein level of Cyclin E was 
found to be enriched in NG2 ICD-transfected Oli-neu cell population compared to 
control (~2 fold), in line with the previous observation (Fig 4.19).  
4.5.2 NG2 ICD overexpression is associated with changed nuclear morphology in 
OPC 
In their recent paper in 2016, Wang et al. demonstrated the tight coordination between 
nuclear shape and cell-cycle phases using high-resolution microscopy. Recent literature 
also support the notion that nuclear morphology changes with different phases of cell-
cycle and it is reported that in G1 phase most of the cell nuclei appear round. After the 
synthesis and replication phase (late S-phase), the nuclear shape appears like more 
elongated or dumbbell-shaped as cells progress to mitosis (Wang et al., 2016). To 
strengthen the result of the newly found ICD-mediated effect on cell-cycle progression, 
investigation on the nuclear morphology in ICD-transfectants using two parameters; 
nuclear area and roundness was performed. Data quantification revealed that nuclear 
roundness was significantly reduced in ICD overexpressing OPC while nuclear area 
was increased around 1.6 fold in ICD overexpressing cells, suggesting a cell-cycle 
progression specific changes brought upon by cleaved NG2 ICD (Fig 4.20). 
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Figure 4.20.  Altered nuclear morphology in ICD-overexpressing cells (A) Immunofluorescent images 
of Oli-neu cells expressing ICD-flag (green). The arrows indicate ICD-transfected cells. (B) Quantification 
of nuclear shape based on two indices (ImageJ); nuclear area (unit for area) and roundness (0.0-1.0), 
revealed that nuclei of ICD-transfected Oli-neu were ~1.6 times larger (area) and less round (roundness) 
than Oli-neu from control (Mean values ±SEM was shown in the data. Total 50 cells were counted from 
three independent experiments (n=3) for each condition. Statistical test was carried out by Mann-Whitney-
rank based test.) (Taken from Nayak T et al., 2018) 
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5. Discussion 
5.1. Sub-cellular localization of the NG2 ICD 
Previous findings on ICDs of type-1 transmembrane proteins shed a major focus on 
nuclear signaling and gene regulation (for example ICDs of Notch or APP protein exert 
a transcriptional role). An initial study by our group also observed the nuclear presence 
of ICD in a preliminary study. Sakry et al., in 2015, found that after transfection, most of 
the protein was localized in the cytoplasm with a lower nuclear level (Sakry et al., 2015). 
Here, in this study, the same localization pattern was observed, and previous results 
were validated. However, immunofluorescent staining of cells expressing an NLS-
truncated ICD construct showed only cytoplasmic and no nuclear localization. 
Therefore, it is likely that there is an NLS-dependent transport of the NG2 ICD into the 
cell nucleus. To validate whether NLS-dependent ICD translocation is an active 
process, treatment with an importin inhibitor, Ivermectin, was carried out and the 
observed results indicate an active nuclear targeting of NG2 ICD.  
However, unlike Notch ICD, NG2 ICD does not contain any DNA-binding domain (DBD) 
or transcription factor (TF)-binding/regulatory domain, making it an unlikely event that 
NG2 ICD plays a direct role in transcription regulation by direct binding to DNA or TF. 
IP-MS study was performed from ICD-overexpressing samples to determine if any 
putative candidates could be found in ICD-interactome to explain the nuclear presence 
of the NG2 ICD. Strikingly, ICD-interactome by determined IP-MS revealed that mainly 
cytoplasmic proteins (translation factors, cell-cycle factors) are associated with NG2 
ICD and GO-based analysis of IP-MS candidates suggest an alteration in translation 
and cell-cycle kinetics. Interaction analysis did not provide any conclusive information 
on coprecipitation of cleaved NG2 ICD with nuclear proteins or any such protein 
complex that is known to exhibit nuclear translocation; rather it strongly suggested the 
involvement of translation regulatory pathways which could be a convincing explanation 
for the predominant cytosolic expression of the ICD.  
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5.2. A novel role of NG2 ICD as a regulator of translation and cell-cycle 
progression via modulation of mTOR-signaling cascade 
Based on the results from the ontology analysis of proteomics data, the effect of the 
NG2 ICD on mRNA translation and cell-cycle kinetics was investigated. 
Interestingly, ICD was shown to co-precipitate with translation factors and total 
translation was increased by ~70% by NG2 ICD overexpression, but only slightly and 
not significantly by NG2 DEL expression in OPC and HEK cells. Results from previous 
(Sakry et al., 2015) and the present study has shown that the membrane-bound NG2 
CTF, but not the ICD, is the major fragment generated after NG2 DEL expression. While 
investigating the molecular mechanism behind the ICD-mediated translation regulation, 
at first the involvement of the global translator regulator mTORC1 was demonstrated by 
treating the cells with a specific mTORC1-inhibitor, and then mTOR-signaling cascade 
upon ICD overexpression was studied in both cell line. Increased phosphorylation of the 
mTOR-signaling components was found in ICD-overexpressing cells compared to 
control, confirming an active mTORC1-cascade.  
NG2 ICD has also been found to play a role in regulating cell-cycle kinetics. Cell cycle 
analysis of FACS-sorted ICD-transfectants from HEK cells demonstrated a 10% shift 
towards S-phase, reflecting increased DNA replication in the HEK cell population. 
Immunofluorescent staining of Oli-neu cells using a specific S-phase protein marker 
(PCNA) also revealed an increase of PCNA+ cells in the ICD-overexpressing population 
(21.04%) compared to control (9.33%), thus establishing a novel role for NG2 ICD in 
cell-cycle progression. Changes in nuclear morphology of ICD-transfected OPC were 
also detected in line with the observed alterations in nuclear shape reported in S-phase 
cells (Wang et al., 2016) and many recent literatures provide information on 
interconnection between cell-cycle progression and altered nuclear morphology (Xue et 
al., 2013, Schlaitz et al., 2013).  
Progression through different stages of the cell-cycle requires that a proliferating cell 
gains sufficient energy and cell mass and emerging reports have demonstrated that 
genes involved in regulating protein biosynthesis, DNA repair, replication, 
nucleocytoplasmic transport are upregulated as cells progress from G1 to S-phase  
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Fig 5.1. Role of mTOR signaling in controlling cellular growth (Taken from Fingar et al., 2002) 
 
(Stumph et al., 2014, Aviner, et al., 2015).  It has been shown that nutrients, growth 
factors and mTOR, in an orchestrated action, mediate specific checkpoints during G1-
phase (R-point and late G1-phase metabolic checkpoint) where it is decided whether 
the cell contains optimal size and nutrients to accomplish replication phase (S-phase) 
(Foster et al., 2010, Saqcena et al., 2013). The downstream components of mTOR, 
S6K1 and eIF4B, are also tightly linked with G1 to S-phase progression as their 
increased phosphorylation is correlated with accelerated cellular growth and 
proliferation (Fingar et al. 2004., Gingras et al., 2001) (Fig 5.1). mTOR-S6K1 signaling 
has also been found to control transcription of CHK1 via Rb-E2F pathway by 
upregulating Cyclin D and Cyclin E (Zhou et al., 2017), and inhibition of active mTOR-
signaling causes slower S-phase progression of cells following DNA-damage. 
Interestingly, we found increased Cyclin E1 expression in ICD-overexpressing Oli-neu 
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cells. Therefore, it is very likely that ICD-mediated translational upregulation is coupled 
with the increased G1 to S-phase progression and mTORC1, upon activated by 
released NG2 ICD, plays a pivotal role in regulating these phenomena.  
These results are particularly promising because so far, NG2 has not been reported to 
have direct effects on translation, and this study for the first time shows that NG2 ICD, 
specifically, alters translation and cell-cycle kinetics and thus displays a unique 
functional property. However, cell proliferation has been associated with NG2 
expression, since OPC are the only proliferating cell population in the adult unlesioned 
mammalian CNS, apart from stem cells (Simon et al., 2011, Dimou et al., 2014). The 
ICD-mediated drive towards S-phase progression in OPC is striking as recent literature 
found that stimulation of neuronal circuits causes an increase in adjacent neuronal 
progenitor proliferation, including NG2+ OPC (Gibson et al.; 2014, Reviewed in Forbes 
and Gallo, 2017). Since neuronal activity stimulates NG2 cleavage leading to the 
increased cytoplasmic release of NG2 ICD (Sakry et al., 2014), the observation of ICD-
mediated cell-cycle progression is of interest in this context.  
5.3. NG2 ICD regulates FMRP, an activity-dependent, a neuronal protein involved 
in local translation 
As discussed in detail in the Results Section, Fragile X protein (FMRP) is an RNA 
binding protein with demonstrated roles in mRNA transport, localization, stability, and 
translation. FMRP is a neuronal protein which exerts its regulatory effect upon receiving 
neuronal stimuli. To date, the targets of FMRP and its role in translation are well-
established in neurons only, where it plays a pivotal role in regulating local translation, 
via its role as a translation repressor.  Investigation on how FMRP loss is related to 
elevated translation revealed that FMRP controls the expression of two key components 
of the phosphoinositide 3- kinase (PI3K) signaling cascade: the catalytic subunit, p110β, 
and PI3K enhancer (PIKE) (Fig 5.2). The translation and expression of both are 
elevated in the brains of Fmr1-KO mice (Sharma et al., 2010, Gross C et al., 2010). 
PI3K lies as an upstream activator of the mTOR-signaling pathway, and mTOR-
signaling cascade has also been reported to be hyperactive in the absence of FMRP 
(Sharma et al., 2010, Rehnitz et al., 2017). The translation factor, eEF2, is a reported 
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target of FMRP (Darnell et al., 2013) and in FMRP knockout mice, total eEF2 protein 
and levels of p-eIF4B were higher than in wild-type mice (Bhattacherjee et al., 2012) in 
hippocampal cells. Although the characterization of FMRP has been extensively done in 
neurons, the role of FMRP in glial cells is still in its early days and awaits further 
research. Expression profile of FMRP in glial cells revealed that FMRP expression is 
abundant at post-natal day 0 (PND 0) in astrocytes, OPC and microglia with a gradual 
decline during the developmental course and finally with a low/undetectable level in the 
adult brain in different brain regions (Gholizadeh et al., 2014, Zhang et al., 2014).  
 
 
 
 
 
 
 
 
 
 
Fig 5.2. Crosstalk between FMRP and mTOR signaling pathways. (Taken from Sharma A et al., 
2010) 
FMRP has been found in the soma and distal processes of OPC and immature OLs in 
neonatal brain, in oligodendrocyte cell line and in primary oligodendrocyte cell culture 
(Wang et al., 2004, Pacey et al., 2013). Like in other glial cells, FMRP expression is 
reduced as OPC differentiate into matured OLs, although Giampetruzzi et al., in 2013, 
showed that FMRP expression is detected in matured MBP+ OLs of rodents and human 
OLs. Interestingly, MBP is one known target of FMRP (Darnell et al., 2013) and FMRP 
has been shown to bind MBP and inhibit its translation in vitro (Wang et al., 2004) 
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FMRP-KO mice showed delayed myelination and reduced number of OPCs found in 
deep cerebellar white matter (Pacey et al., 2013).  
Interestingly, we found significant downregulation of FMRP protein levels of 70% 
compared to the normal protein levels in NG2 ICD-overexpressing OPC, but in HEK 
cells overexpressing the NG2 ICD, this regulation was much lower implicating a cell-
specific effect of ICD on FMRP. Since we found reduced FMRP levels and increased 
translation after NG2 ICD overexpression in OPC, it is likely that FMRP also acts as a 
translational repressor in OPC, as well as in neurons. Moreover, eEF2 protein level was 
also higher (~40%) after ICD-overexpression with a reduced eef2 mRNA level, implying 
a potential involvement of post-transcriptional regulation by FMRP. 
5.4. Role of FMRP/eEF2 in synaptic signaling and myelination  
The molecular interplay between FMRP/eEF2/NG2 ICD could have a crucial effect on a 
broader aspect of activity-dependent local translation. FMRP is known to bind and 
repress translation of several dendritic and synaptic mRNAs among which some are 
immediate early genes (IEG) such as CamKII, MAP1B and Arc/Arg 3.1. Upon receiving 
stimulus, translational repression of Arc, exerted by FMRP is relieved, and optimal 
expression level of Arc is attained which is required for AMPAR trafficking and 
internalization (Chowdhury et al., 2006). In 2008, Park et al. showed that eEF2K/eEF2 
and FMRP-dependent translation pathway acts in a coordinated fashion upon receiving 
stimuli and controls the rapid and transient switch of translation factors that are required 
for mGluR-LTD (Park et al., 2008).  
In this context, interestingly, it has been shown that neuronal activity-mediated NG2 
shedding has a significant impact on the neuronal glutamate receptor currents and 
synaptic strength in somatosensory cortex (Sakry et al., 2014), further showing the 
importance of precise control of synaptic receptors and the optimal expression of their 
pivotal regulatory proteins in a timely manner.  
In addition to controlling local translation, FMRP is also known to bind and exerts 
stabilization factor on its mRNA targets. Among many identified FMRP-mRNA targets, 
two of the most relevant candidates are PSD95 and MBP mRNA. For PSD-95, It has 
Discussion 
 
94 | P a g e  
 
been shown that FMRP binds to its 3’-UTR and stabilizes the mRNA and a loss of 
FMRP results in a reduction of this essential synaptic protein (Zalfa et al., 2007).  
MBP and the control of myelination by FMRP it still a topic of debate. Several groups 
reported that FMRP binds MBP mRNA in vitro and in vivo and inhibits MBP protein 
expression in vitro (Li et al., 2001, Wang et al., 2004, Darnell et al., 2011, Giampetruzzi 
et al., 2013).  As FMRP expression gradually declines as OPC mature into OLs, it is 
likely that FMRP-mediated translational repression of MBP mRNA is relieved in mature 
OLs, allowing abundant expression of MBP protein. Massive reduction of MBP protein 
and thinner myelination is observed at postnatal day (PND) 7 in cerebellum of FMRP-
KO mice compared to wildtype (Giampetruzzi et al., 2013, Pacey et al., 2013) and this 
altered expression returned to normal levels by PND-30, suggesting that impaired 
development of OPC caused a delayed myelination in this context.  
A mRNA-stabilization study in ICD-overexpressing Oli-neu cells has been done, and 
strikingly, the data revealed reduced stability of both PSD-95 and MBP mRNA in 
cultured OPC (Oli-neu). This observation could be explained by ICD-mediated 
downregulation of FMRP which eventually leads to less stabilization effect on the target 
mRNA. Thus, the control of FMRP by NG2 ICD is of great importance as FMRP plays a 
potential role in OPC maturation and myelination.  
In this study, two translation-related pathways are found to be affected by the NG2 ICD. 
One is responsible for general translation regulation in cells (mTOR/S6K1 signaling 
cascade), and the other one is important for regulating local translation and synaptic 
strength including LTD (FMRP-eEF2) in neurons (Park et al., 2008). Recent studies 
have shown that FMRP also activates the mTOR-signaling pathway in neurons 
(Bhattacharjee et al., Sharma et al., J neuro, 2010), combining these two signaling 
cascades. (Fig 5.3) 
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Fig 5.3. Model depicting altered signaling pathways by cleaved NG2 ICD (Taken from Nayak T et 
al., 2018) 
 
5.5. NG2 ICD causes upregulation of proteins involved in cellular differentiation 
and tumouriogenesis  
Interestingly, KEGG pathway analysis of pSILAC data revealed that the set of proteins 
involved in cell cycle regulation (p = 2.6E-1) and transcriptional regulation (p = 7.5E-1) 
was highly enriched among the up-regulated proteins. Among them, syntenin1 is 
already a known binding partner of ICD (Chatterjee et al., 2008) and known to regulate 
G1 to S-phase progression (Kashyap et al.; 2015). Several transcription factors were 
enriched in pSILAC, among which Phldb1, Sdcbp, and Adnp are involved in cell 
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differentiation. Recent evidence suggests phldb1 is one of the top regulated genes in 
glioma and Knockdown of phldb1 in U87MG cells had a significant impact on cell 
viability due to increased cell death (Baskin et al.; 2015). Phldb1 also facilitates 
insulin-dependent Akt phosphorylation and is involved in adipocyte differentiation.  
Activity-dependent neuroprotector homeobox protein (ADNP) was initially identified in 
brain tissue with transcription factor activity and is essential for proper neuronal 
development and cranial neural tube closure (Pinhasov A et al., 2003). To date, ADNP 
is known to repress expression of genes involved in transcriptional regulation, 
neurogenesis and organogenesis and evidence supports that ADNP directly interacts 
with chromatin-remodeling complex associated with cellular differentiation (Mandel S et 
al., 2007). Studies have also shown that ADNP has a high abundance in proliferative 
tissues and promotes tumourigenesis and cancer cell survival (Zamostiano et al., 2001, 
Bassan M et al.,1999) and inhibition of ADNP protein expression caused a significant 
reduction in metabolic activity in the target cells coupled with increases in the tumour 
suppressor p53 (Amson R; 2000).  
Interestingly, RNA-Seq data obtained from www.brainrnaseq.org showed that ADNP 
has the highest expression in OPC amongst all glial cells and its expression is reduced 
as OPC progress towards the maturation stage. In addition, ADNP was one of the most 
consistently found, top-regulated proteins altered upon ICD-overexpression. Hence, we 
studied ADNP total protein expression and found a significantly higher level (~40%) of 
ADNP in ICD-overexpressing OPC, further opening new avenues for studying cellular 
differentiation and gene regulation.  
5.6. NG2 ICD signaling in Tumours 
Interestingly, dysregulation of the FMRP/Akt/mTOR pathway has been reported to 
promote tumourigenesis (Luca et al., 2013, Rajasekhar et al., 2003) and impaired 
mTOR cascade has especially been linked with Glioblastoma, the most common form of 
primary brain tumour. (Akhavan et al., 2010, Hu et al., 2005). NG2 has been shown to 
be abundantly expressed by high proliferative tumour cells in melanomas and gliomas 
(Al-Mayhani et al., 2011; Chekenya et al., 2008; Persson et al., 2010). The migration-
promoting function of NG2 (Biname et al., 2013), as well as the binding to OMI/HtrA2 
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(Maus et al., 2015), features favoring NG2 expression by tumour cells promoting 
invasion and increasing resistance to oxidative stress. NG2 is included in a pool of 
several antigens used in a vaccine therapy against glioblastoma multiform, which 
reduces tumour growth (Poli A, 2013). Additionally, OPC are discussed as the major 
cells of origin for gliomas (Liu et al., 2012). NG2 is also involved in regulating symmetric 
versus asymmetric cell-division of OPC, the mode of division influences the likelihood of 
an OPC to become a tumour cell (Sugiarto et al., 2011). The findings of increased 
translation and DNA-synthesis (S-phase) by NG2 ICD correlates with the high 
proliferation and expression rates of these NG2-expressing tumours. These data also 
matches with the molecular signature of NG2+ GBMs which revealed that genes 
associated with proliferation and cell-cycle (MCCM, DNA replication and repair, E2F, 
MELK, nucleotide metabolism) were overrepresented in those tumour cells (Al-Mayhani 
et al., 2011), and ICD-mediated effects are therefore likely to be contributing factors to 
increased translation and DNA-synthesis within these tumours.  
5.7. Physiological Impact of NG2 cleavage 
NG2 cleavage has a multimodal effect in OPC biology. NG2, being a type-1 
transmembrane protein is subjected to intramembrane proteolysis and generates an 
extracellular domain, CTF and intracellular domain (ICD).  
This study, for the first time, revealed distinct roles of the NG2 intracellular region and 
provided evidence for cleaved NG2 ICD as a functional domain which adds new insights 
on the impact of NG2 cleavage in OPC and tumour signaling pathways (altered 
mTOR/FMRP). In addition to effects of the released NG2 ectodomain on the 
glutamatergic properties of neurons (Sakry et al., 2014), it has been shown here that the 
released NG2 ICD affects translation and cell-cycle kinetics and regulates expression of 
proteins specific to the p53 regulatory pathway and cell differentiation. These effects are 
important both for normal OPC as well as NG2 expressing tumours. Importantly, NG2 
cleavage also could take place at the Neuron-OPC synapse where mRNAs are 
localized and stored (including MBP mRNA) and FMRP is likely to play a translation 
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repressor role in OPC as evident from this study. It would be interesting to investigate 
how ICD-mediated effect on FMRP downregulation alters the dynamics of local 
translation upon receiving stimuli. Moreover, these newly identified, altered (by NG2 
ICD) signaling pathways in OPC can be influenced by the neuronal network and play an 
enormous role in controlling synaptic strength (Fig 5.4). It has also been shown that 
activity stimulates NG2 cleavage and influences OPC proliferation (Mangin et al., 2012), 
which could be explained by ICD-mediated drive for cell-cycle progression found in this 
study.  
 
Fig 5.4. Model depicting NG2 cleavage and the main functions of the cleaved NG2 products in 
OPC 
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5.8. Future directions 
This study demonstrated the functional properties of the cleaved NG2 ICD. These 
findings provide new insights for further research on NG2+OPC biology. Future studies 
should address the role of nuclear ICD (although proven to have a lower nuclear 
expression) in more detail. Since ICD significantly downregulates FMRP expression in 
OPC, the mechanism behind this downregulation needs to be investigated. This is 
especially important as FMRP has been shown to translocate to nucleus owing to its 
NLS domains and actively participates in chromatin remodeling and p53-induced DNA-
damage response. As discussed above, ICD-mediated de novo proteome also 
represents a large fraction of DNA replication and p53- regulatory proteins and the 
molecular interrelation between ICD and FMRP could have a significant effect on OPC 
chromatin-remodeling and gene expression that has not been addressed in this study.  
Moreover, cleaved NG2 ICD and FMRP are colocalized at OPC processes. It has been 
shown in this study that FMRP also acts as a translation repressor in NG2+ OPC, which 
serve as a post-synaptic compartment, and FMRP plays an important role in controlling 
local translation upon receiving stimuli. Therefore, the negative regulation of ICD on 
FMRP protein levels could exert an aberrant and impaired local translation in NG2+ 
OPC, which would be intriguing to investigate. The effect of FMRP downregulation on 
its target MBP mRNA in OPC could play a crucial role in OPC maturation. Preliminary 
data in this study already has shown an ICD-dependent effect on MBP mRNA 
stabilization and awaits further research.  
It would be intriguing to investigate effects of cleaved ICD in NG2-expressing tumours 
and if ICD promotes or inhibits tumouriogenesis in these cells which hold great potential 
for future NG2 therapeutic approaches to treat NG2+ GBMs.  
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